Page last updated: 2024-10-28

glyburide and Disease Models, Animal

glyburide has been researched along with Disease Models, Animal in 188 studies

Glyburide: An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide
glyburide : An N-sulfonylurea that is acetohexamide in which the acetyl group is replaced by a 2-(5-chloro-2-methoxybenzamido)ethyl group.

Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.

Research Excerpts

ExcerptRelevanceReference
" In this study, we investigated the possible beneficial effects of lasmiditan and sumatriptan against post-stroke seizures in mice and explored underlying mechanisms in their effects."8.12Neuroprotective effects of Lasmiditan and Sumatriptan in an experimental model of post-stroke seizure in mice: Higher effects with concurrent opioid receptors or K ( Amanlou, A; Dehpour, AR; Ejtemaei-Mehr, S; Eslami, F; Ghasemi, M; Rahimi, N; Rashidian, A; Shayan, M; Solaimanian, S, 2022)
" Many of these compounds, including olanzapine, cause metabolic side-effects such as impaired glucose tolerance and insulin resistance."7.80Antidiabetic-drug combination treatment for glucose intolerance in adult female rats treated acutely with olanzapine. ( Asiri, Y; Barr, AM; Boyda, HN; Honer, WG; Lo, R; Pang, CC; Procyshyn, RM; Wang, CK; Wu, C, 2014)
"This study investigated the role of K(ATP) channels in morphine-induced antinociception and hepatic oxidative stress in acute and inflammatory pain."7.79The involvement of K(ATP) channels in morphine-induced antinociception and hepatic oxidative stress in acute and inflammatory pain in rats. ( Afify, EA; Khedr, MM; Nasser, SA; Omar, AG, 2013)
"We evaluate the effectiveness of nicorandil on warm ischemia-reperfusion injury of the small intestine in a canine model."7.77The effect of nicorandil on small intestinal ischemia-reperfusion injury in a canine model. ( Arakawa, K; Matsumoto, K; Oshima, K; Sato, H; Suto, Y; Takeyoshi, I; Yamazaki, H, 2011)
"To observe and compare the effect of taurine on contractions of aortic rings isolated from normal (NC) and insulin resistance (IR) Sprague-Dawley rats, and to explore its underlying mechanism(s)."7.74Effects of taurine on aortic rings isolated from fructose-fed insulin resistance Sprague-Dawley rat are changed. ( Li, J; Liang, Y; Niu, L; Wu, D; Xue, W; Zhang, M, 2008)
"The present study was designed to evaluate the effects of a potassium channel opener, nicorandil, and to elucidate its possible mechanism of action in aspirin plus pylorus ligation induced and ethanol-induced gastric ulcers in rats."7.71Evaluation of the effects of nicorandil on experimentally induced gastric ulcers. ( Goswami, SG; Patel, HM; Santani, DD, 2001)
"Hydrogen sulfide (H(2)S) is an endogenous gaseous mediator of mucosal defense with antiinflammatory effects that promote ulcer healing."5.35Endogenous and exogenous hydrogen sulfide promotes resolution of colitis in rats. ( Dicay, M; Martin, GR; McKnight, W; Vong, L; Wallace, JL, 2009)
" In this study, we investigated the possible beneficial effects of lasmiditan and sumatriptan against post-stroke seizures in mice and explored underlying mechanisms in their effects."4.12Neuroprotective effects of Lasmiditan and Sumatriptan in an experimental model of post-stroke seizure in mice: Higher effects with concurrent opioid receptors or K ( Amanlou, A; Dehpour, AR; Ejtemaei-Mehr, S; Eslami, F; Ghasemi, M; Rahimi, N; Rashidian, A; Shayan, M; Solaimanian, S, 2022)
"Empagliflozin (EMPA) is a sodium-glucose transporter 2 (SGLT2) inhibitor that functions as a new-generation glucose-lowering agent and has been proven to be beneficial for patients with cardiovascular diseases."4.02Characteristics of Ventricular Electrophysiological Substrates in Metabolic Mice Treated with Empagliflozin. ( Chou, TW; Jhuo, SJ; Lai, WT; Lee, KT; Lin, YH; Liu, IH; Tasi, WC; Wu, BN, 2021)
" This study was conducted to investigate whether or not triamterene, a K(+)-sparing diuretic, can generate protection against seizures induced by intravenous or intraperitoneal pentylenetetrazole (PTZ) models."3.83A role for ATP-sensitive potassium channels in the anticonvulsant effects of triamterene in mice. ( Almasirad, A; Barati, S; Ghasemi, M; Moezi, L; Shafaroodi, H, 2016)
" Many of these compounds, including olanzapine, cause metabolic side-effects such as impaired glucose tolerance and insulin resistance."3.80Antidiabetic-drug combination treatment for glucose intolerance in adult female rats treated acutely with olanzapine. ( Asiri, Y; Barr, AM; Boyda, HN; Honer, WG; Lo, R; Pang, CC; Procyshyn, RM; Wang, CK; Wu, C, 2014)
"This study investigated the role of K(ATP) channels in morphine-induced antinociception and hepatic oxidative stress in acute and inflammatory pain."3.79The involvement of K(ATP) channels in morphine-induced antinociception and hepatic oxidative stress in acute and inflammatory pain in rats. ( Afify, EA; Khedr, MM; Nasser, SA; Omar, AG, 2013)
" We further show, for the first time in any model of sepsis, that glyburide acts as an anti-inflammatory agent by reducing IL1β secretion accompanied by diminished cellular influx and reduced bacterial dissemination to distant organs."3.79Glyburide reduces bacterial dissemination in a mouse model of melioidosis. ( Bast, A; Breitbach, K; de Jong, HK; Hoogendijk, AJ; Kager, LM; Koh, GC; Krause, K; Peacock, SJ; Steinmetz, I; van der Poll, T; Weehuizen, TA; Wiersinga, WJ, 2013)
" We have previously demonstrated that mesenteric lymphatic pumping was compromised in the guinea pig model of 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced ileitis, corroborating clinical and experimental observations of a dilated and/or obstructed phenotype of these vessels in inflammatory bowel disease."3.79Involvement of the NO-cGMP-K(ATP) channel pathway in the mesenteric lymphatic pump dysfunction observed in the guinea pig model of TNBS-induced ileitis. ( Mathias, R; von der Weid, PY, 2013)
"We evaluate the effectiveness of nicorandil on warm ischemia-reperfusion injury of the small intestine in a canine model."3.77The effect of nicorandil on small intestinal ischemia-reperfusion injury in a canine model. ( Arakawa, K; Matsumoto, K; Oshima, K; Sato, H; Suto, Y; Takeyoshi, I; Yamazaki, H, 2011)
"This study was designed to elucidate the contribution of adenosine A(2A) and A(2B) receptors to coronary reactive hyperemia and downstream K(+) channels involved."3.76Contribution of adenosine A(2A) and A(2B) receptors to ischemic coronary dilation: role of K(V) and K(ATP) channels. ( Berwick, ZC; Dick, GM; Lynch, B; Payne, GA; Sturek, M; Tune, JD, 2010)
"To observe and compare the effect of taurine on contractions of aortic rings isolated from normal (NC) and insulin resistance (IR) Sprague-Dawley rats, and to explore its underlying mechanism(s)."3.74Effects of taurine on aortic rings isolated from fructose-fed insulin resistance Sprague-Dawley rat are changed. ( Li, J; Liang, Y; Niu, L; Wu, D; Xue, W; Zhang, M, 2008)
"The role of K(ATP) channels in the antiarrhythmic effect of Escherichia coli endotoxin-induced nitric oxide synthase (iNOS) was examined in an anesthetised rat model of myocardial ischemia and reperfusion arrhythmia by using glibenclamide (1 mg kg(-1)), nateglinide (10 mg kg(-1)) and repaglinide (0."3.74Glibenclamide attenuates the antiarrhythmic effect of endotoxin with a mechanism not involving K(ATP) channels. ( Erkent, U; Ertunc, M; Guc, MO; Ilhan, M; Iskit, AB; Onur, R, 2007)
"We assessed whether pravastatin attenuates cardiac sympathetic reinnervation after myocardial infarction through the activation of ATP-sensitive K(+) (K(ATP)) channels."3.74Effect of pravastatin on sympathetic reinnervation in postinfarcted rats. ( Chang, NC; Lee, TM; Lin, MS, 2007)
" We examined KATP channel modulation in renal ischemia-reperfusion injury (IRI), using an isolated perfused rat kidney (IPRK) model, in control, IRI, IRI+200 microM diazoxide (a KATP opener), IRI + 10 microM glibenclamide (a KATP blocker) and IRI + 200 microM diazoxide + 10 microM glibenclamide groups."3.72ATP-dependent K+ channels in renal ischemia reperfusion injury. ( Endre, ZH; Gobé, GC; Rahgozar, M; Willgoss, DA, 2003)
"The present study was designed to evaluate the effects of a potassium channel opener, nicorandil, and to elucidate its possible mechanism of action in aspirin plus pylorus ligation induced and ethanol-induced gastric ulcers in rats."3.71Evaluation of the effects of nicorandil on experimentally induced gastric ulcers. ( Goswami, SG; Patel, HM; Santani, DD, 2001)
" This study also investigates the effects of a mild epileptic insult on neuronal death in rat hippocampus after a subsequent, lethal epileptic stress using kainic acid (KA) as a model of epilepsy."3.70Mutually protective actions of kainic acid epileptic preconditioning and sublethal global ischemia on hippocampal neuronal death: involvement of adenosine A1 receptors and K(ATP) channels. ( Blondeau, N; Heurteaux, C; Lazdunski, M; Plamondon, H, 1999)
" This study was designed to determine whether clofilium exhibits antifibrillatory activity in a pinacidil + hypoxia-induced model of ventricular fibrillation (VF) in Langendorff-perfused hearts."3.69Antifibrillatory effects of clofilium in the rabbit isolated heart. ( Chi, L; Friedrichs, GS; Green, AL; Lucchesi, BR, 1994)
"We investigated the effect of ATP-sensitive K+ channel (KATP) openers (pinacidil and cromakalim), and a KATP blocker (glibenclamide) on reperfusion-induced arrhythmias in pentobarbitone-anaesthetized rats."3.69KATP channel modulators increase survival rate during coronary occlusion-reperfusion in anaesthetized rats. ( Baczkó, I; Leprán, I; Papp, JG, 1997)
" Studies were conducted under control conditions and in the presence of four inhibitors of potential mediators of the reactive hyperemia response: the nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester (30 microM), the adenosine antagonist 8-(p-sulfophenyl)theophylline (50 microM), the K+ cyclic adenosine triphosphate-dependent channel antagonist glibenclamide (10 microM), and the cyclooxygenase inhibitor indomethacin (10 microM)."3.69Myocardial reactive hyperemia in experimental chronic heart failure: evidence for the role of K+ adenosine triphosphate-dependent channels and cyclooxygenase activity. ( Dumont, L; Fontaine, E; Jasmin, G; Véronneau, M; Viau, S, 1997)
"Using a transient middle cerebral artery occlusion (tMCAo) rodent model of stroke, we studied two rat cohorts, one without rt-PA and a second cohort treated with rt-PA."1.62Continuous Glibenclamide Prevents Hemorrhagic Transformation in a Rodent Model of Severe Ischemia-Reperfusion. ( Igarashi, T; Kimberly, WT; Sastre, C; Wolcott, Z, 2021)
"The pathogenesis of idiopathic inflammatory myopathy (IIM) is complex and unclear."1.62Study of the correlation between the noncanonical pathway of pyroptosis and idiopathic inflammatory myopathy. ( Chai, K; Deng, R; Ma, M, 2021)
"CS includes dilated vasculature, marked cardiac hypertrophy, and other cardiovascular abnormalities."1.56Glibenclamide reverses cardiovascular abnormalities of Cantu syndrome driven by KATP channel overactivity. ( Chalk, R; Halabi, CM; Harter, TM; Huang, Y; Kovacs, A; McClenaghan, C; Nichols, CG; Remedi, MS; van Haaften, G; Yan, Z, 2020)
"In the model of neuropathic pain, preventive and therapeutic effects were observed."1.51Metformin antinociceptive effect in models of nociceptive and neuropathic pain is partially mediated by activation of opioidergic mechanisms. ( Augusto, PSA; Batista, CRA; Braga, AV; Coelho, MM; Costa, SOAM; Dutra, MMGB; Goulart, FA; Machado, RR; Melo, ISF; Morais, MI; Rodrigues, FF, 2019)
" The effect of drying conditions on the morphology, moisture content, hardness, dosage uniformity, surface characteristics, and drug release mechanism of glibenclamide from the matrices was systematically investigated."1.51Controlled release of glibenclamide from monolithic silica subdermal implants produced by the sol-gel process and its use for hyperglycaemia treatment in a murine model. ( Espinosa-Contreras, C; Flores-Cabrera, Y; Hernández-Abad, VJ; Marroquín-Segura, R; Mora-Guevara, JLA; Sánchez-González, EG, 2019)
"Glibenclamide may reduce cerebral edema by inhibiting sulfonylurea receptor-1 (Sur1); its effect on diffuse cerebral edema exacerbated by hypotension/resuscitation is unknown."1.48Glibenclamide Produces Region-Dependent Effects on Cerebral Edema in a Combined Injury Model of Traumatic Brain Injury and Hemorrhagic Shock in Mice. ( Hoshitsuki, K; Jackson, TC; Janesko-Feldman, KL; Jha, RM; Kochanek, PM; Minnigh, MB; Molyneaux, BJ; Park, SY; Poloyac, S; Vagni, VA; Wallisch, JS, 2018)
"Successful rat models for preeclampsia were confirmed based on mean arterial pressure, a 24-h protein urine test, and by observing the structure of the kidney by transmission electron microscopy (TEM)."1.48Role of AKR1C3 in renal injury and glibenclamide is anti-inflammatory in preeclamptic rats. ( Jin, Y; Li, L; Liu, XW; Sun, CJ; Zhang, WY, 2018)
"Cerebral edema is one of the major causes of mortality following cardiac arrest (CA) and cardiopulmonary resuscitation (CPR)."1.48Glibenclamide and Therapeutic Hypothermia Have Comparable Effect on Attenuating Global Cerebral Edema Following Experimental Cardiac Arrest. ( Isaka, Y; Nakamura, T; Nakayama, S; Taguchi, N; Tanaka, M, 2018)
"Meanwhile, cerebral edema, as well as neuronal loss, was decreased in several brain areas in the GBC group."1.46Glibenclamide ameliorates cerebral edema and improves outcomes in a rat model of status epilepticus. ( Gu, Y; Hu, Y; Huang, H; Huang, K; Ji, Z; Lin, Z; Pan, S; Wang, S; Wu, Y; Yang, T, 2017)
" All of these efforts led to the identification of compound 11 as a potent and orally bioavailable FFA1 agonist without the risk of hypoglycemia."1.43Discovery of novel pyrrole-based scaffold as potent and orally bioavailable free fatty acid receptor 1 agonists for the treatment of type 2 diabetes. ( Cai, X; Dai, Y; Fu, M; Huang, W; Li, Z; Pan, M; Qian, H; Shi, W; Su, X, 2016)
"Glibenclamide and thymoquinone plasma concentrations were analysed using a sensitive RP-HPLC method, and non-compartmental model pharmacokinetic parameters were calculated."1.42Effects of Thymoquinone on the Pharmacokinetics and Pharmacodynamics of Glibenclamide in a Rat Model. ( Ahmad, A; Al-Jenoobi, FI; Al-Mohizea, AM; Alkharfy, KM; Khan, RM; Raish, M, 2015)
"Metformin promotes irisin release from murine skeletal muscle into blood, independently of AMPK pathway activation."1.42Metformin promotes irisin release from murine skeletal muscle independently of AMP-activated protein kinase activation. ( Deng, YP; Huang, F; Jiang, GJ; Li, DJ; Lu, WJ; Shen, FM, 2015)
"The rat model of bone cancer pain was induced by implanting rat mammary gland carcinoma cells (Walker256) into the tibias."1.40Role of ATP-sensitive potassium channels in modulating nociception in rat model of bone cancer pain. ( Fan, L; Pan, HL; Ren, J; Tian, Y; Wang, X; Wang, Y; Wu, J; Xia, H; Xu, L; Yang, S; Yao, W; Zhang, C; Zhang, D, 2014)
"The citronellal was able to increase the pain threshold in the DA test (p < 0."1.39Citronellal, a monoterpene present in Java citronella oil, attenuates mechanical nociception response in mice. ( Almeida, JR; Camargo, EA; de Oliveira, AP; de Oliveira, MG; de Santana, MT; De Sousa, DP; Quintans-Júnior, LJ; Santana, DG; Santana, MF, 2013)
"Diabetes can exacerbate seizures and worsen seizure-related brain damage."1.39Pregabalin attenuates excitotoxicity in diabetes. ( Cheng, JT; Huang, CC; Huang, CW; Lai, MC; Tsai, JJ; Wu, SN, 2013)
"Treatment with naloxone, L-arginine and glibenclamide reversed the effect of LPEF in glutamate test."1.39Antinociceptive effect of Lecythis pisonis Camb. (Lecythidaceae) in models of acute pain in mice. ( Almeida, FR; Brandão, MS; Chaves, MH; Ferreira, EL; Lima, DF; Oliveira, JP; Pereira, SS, 2013)
"Riluzole is a pleotropic drug that blocks "persistent sodium currents" in neurons, but in SCI, its molecular mechanism of action is uncertain."1.38Comparative effects of glibenclamide and riluzole in a rat model of severe cervical spinal cord injury. ( Gerzanich, V; Ivanov, A; Ivanova, S; Keledjian, K; Simard, JM; Tsymbalyuk, O, 2012)
"Risperidone has been used in some stress disorders and may be potentially protective against stress-induced gastric lesions."1.37Gastroprotective potential of risperidone, an atypical antipsychotic, against stress and pyloric ligation induced gastric lesions. ( Krishnamurthy, S; Saxena, B; Singh, S, 2011)
"Glyburide (GLB) is an oral sulfonylurea, commonly used for the treatment of gestational diabetes mellitus."1.36Increased glyburide clearance in the pregnant mouse model. ( Hebert, MF; Mao, Q; Unadkat, JD; Zhang, Y; Zhou, L, 2010)
"Hydrogen sulfide (H(2)S) is an endogenous gaseous mediator of mucosal defense with antiinflammatory effects that promote ulcer healing."1.35Endogenous and exogenous hydrogen sulfide promotes resolution of colitis in rats. ( Dicay, M; Martin, GR; McKnight, W; Vong, L; Wallace, JL, 2009)
"To create HT model, right middle cerebral artery occlusion (MCAO) was conducted with intraluminal thread technique; 30 min after MCAO, 50 microL arterial blood was injected into the caudate nucleus where the infarction occurred."1.35Brain damage related to hemorrhagic transformation following cerebral ischemia and the role of K ATP channels. ( Li, LT; Yang, Y; Yin, J; Zhang, XJ, 2008)
"10% glycerol solution was able to prevent microvascular alterations due to BCCAO protecting cerebral tissue."1.35Pial microvascular responses to transient bilateral common carotid artery occlusion: effects of hypertonic glycerol. ( Colantuoni, A; Lapi, D; Marchiafava, PL, 2008)
"Cardiac dysfunction during hemorrhagic shock (HS) is associated with myocardial ischemia, during which adenosine triphosphate (ATP)-sensitive potassium (K(ATP)) channels can be activated."1.35Adenosine triphosphate-sensitive potassium channels prevent extension of myocardial ischemia to subepicardium during hemorrhagic shock. ( Adachi, T; Aikawa, N; Hori, S; Inoue, S; Miyazaki, K; Mori, H; Nakagawa, M; Nakazawa, H; Ogawa, S; Suzuki, M, 2008)
"The R6/2 transgenic mouse model of Huntington's disease (HD) develops a progressive neurological phenotype that involves severe motor and cognitive dysfunctions."1.33Atypical diabetes associated with inclusion formation in the R6/2 mouse model of Huntington's disease is not improved by treatment with hypoglycaemic agents. ( Hunt, MJ; Morton, AJ, 2005)
"Cardiac hypertrophy has been demonstrated to decreases the ATP-sensitive potassium channels (K(ATP)), the major protective mechanism following the energy depletion, a common condition seen during the reperfusion after open heart surgery."1.32Ischemic preconditioning prevents reperfusion heart injury in cardiac hypertrophy by activation of mitochondrial KATP channels. ( Maeda, H; Rajesh, KG; Sasaguri, S; Suzuki, R; Xing, Y, 2004)
"The influence of left ventricular hypertrophy (LVH) on the endothelial function of resistance endocardial arteries is not well established."1.32Loss of endothelial KATP channel-dependent, NO-mediated dilation of endocardial resistance coronary arteries in pigs with left ventricular hypertrophy. ( Gendron, ME; Perrault, LP; Thorin, E, 2004)
"Hypercholesterolemia was induced by two weeks of cholesterol-enriched diet."1.31K(ATP) channel opening is an endogenous mechanism of protection against the no-reflow phenomenon but its function is compromised by hypercholesterolemia. ( Genda, S; Ichikawa, Y; Miki, T; Miura, T; Shimamoto, K, 2002)
" The dose-response curve of insulin secretion showed a markedly reduced maximum response, but almost normal glucose sensitivity in NSY islets."1.31Insulin secretion to glucose as well as nonglucose stimuli is impaired in spontaneously diabetic Nagoya-Shibata-Yasuda mice. ( Babaya, N; Hamada, Y; Ikegami, H; Kawaguchi, Y; Nojima, K; Ogihara, T; Shibata, M; Ueda, H; Yamada, K; Yamato, E, 2001)
"Pretreatment with diazoxide (10 mg."1.29Effects of diazoxide on norepinephrine-induced vasocontraction and ischemic myocardium in rats. ( Ichihara, K; Nakai, T, 1994)
"Hemorrhagic shock is associated with early vasomotor paralysis as well as with early derangements in the intracellular metabolic status."1.29Inhibition of ATP-activated potassium channels exerts pressor effects and improves survival in a rat model of severe hemorrhagic shock. ( Salzman, AL; Szabó, C, 1996)
"In both the stunned myocardium model as well as the infarcted myocardium model, the beneficial effects of the potassium channel openers could not be attributed to differences in the traditional determinants of the extent of ischaemia/reperfusion injury; area at risk size, oxygen consumption, or collateral blood flow."1.29Cardioprotective actions of potassium channel openers. ( Auchampach, JA; Gross, GJ; Maruyama, M, 1994)

Research

Studies (188)

TimeframeStudies, this research(%)All Research%
pre-19902 (1.06)18.7374
1990's25 (13.30)18.2507
2000's62 (32.98)29.6817
2010's80 (42.55)24.3611
2020's19 (10.11)2.80

Authors

AuthorsStudies
Navarrete-Vazquez, G2
Paoli, P1
León-Rivera, I2
Villalobos-Molina, R1
Medina-Franco, JL2
Ortiz-Andrade, R1
Estrada-Soto, S2
Camici, G1
Diaz-Coutiño, D1
Gallardo-Ortiz, I1
Martinez-Mayorga, K1
Moreno-Díaz, H1
Torres-Gómez, H1
Hidalgo-Figueroa, S1
Ramírez-Espinosa, JJ1
Alarcón-Aguilar, FJ1
Almanza-Pérez, JC1
Li, Z1
Pan, M1
Su, X1
Dai, Y1
Fu, M1
Cai, X1
Shi, W1
Huang, W1
Qian, H1
Solinski, HJ1
Dranchak, P1
Oliphant, E1
Gu, X1
Earnest, TW1
Braisted, J1
Inglese, J1
Hoon, MA1
Abrams, RPM1
Yasgar, A1
Teramoto, T1
Lee, MH1
Dorjsuren, D1
Eastman, RT1
Malik, N1
Zakharov, AV1
Li, W1
Bachani, M1
Brimacombe, K1
Steiner, JP1
Hall, MD1
Balasubramanian, A1
Jadhav, A1
Padmanabhan, R1
Simeonov, A1
Nath, A1
Mohammadi, S1
Fakhri, S1
Mohammadi-Farani, A1
Farzaei, MH1
Abbaszadeh, F1
Ferdowsi, S1
Abdolmaleki, A1
Asadi, A1
Zahri, S1
Shayan, M1
Eslami, F1
Amanlou, A1
Solaimanian, S1
Rahimi, N1
Rashidian, A1
Ejtemaei-Mehr, S1
Ghasemi, M4
Dehpour, AR4
Zusman, BE1
Wu, Y2
Kochanek, PM2
Vagni, VE1
Janesko-Feldman, K1
Gerzanich, V11
Simard, JM11
Karahalios, K1
Mihaljevic, S1
Raikwar, S1
Rani, A1
Rulney, J1
Desai, SM1
Catapano, J1
Jha, RM2
Yang, X3
Qu, C1
Jia, J1
Zhan, Y1
Esmaeili, MH2
Enayati, M1
Khabbaz Abkenar, F1
Ebrahimian, F1
Salari, AA2
Jacobson, SM1
MacAllister, TW1
Geliebter, DM1
McClenaghan, C1
Huang, Y1
Yan, Z1
Harter, TM1
Halabi, CM1
Chalk, R1
Kovacs, A1
van Haaften, G1
Remedi, MS1
Nichols, CG1
Hirshman, NA1
Hughes, FM3
Jin, H3
Harrison, WT1
White, SW1
Doan, I1
Harper, SN1
Leidig, PD1
Purves, JT3
Wang, Z2
Jia, X1
Kasabov, KA1
Kudryashov, NV1
Volkova, AV1
Shimshirt, AA1
Kalinina, TS1
Zhmurenko, LA1
Voronina, TA1
Wachal, Z1
Bombicz, M1
Priksz, D1
Hegedűs, C1
Kovács, D1
Szabó, AM1
Kiss, R1
Németh, J1
Juhász, B1
Szilvássy, Z2
Varga, B1
Liu, H1
Gu, C1
Liu, M1
Liu, G1
Wang, Y3
Ju, YJ1
Kim, N1
Gee, MS1
Jeon, SH1
Lee, D1
Do, J1
Ryu, JS1
Lee, JK1
Rosado, AF1
Rosa, PB1
Platt, N1
Pierone, BC1
Neis, VB1
Severo Rodrigues, AL1
Kaster, MP1
Kaufmann, FN1
Igarashi, T1
Sastre, C1
Wolcott, Z1
Kimberly, WT1
Qiu, X1
Wang, Q2
Hou, L1
Zhang, C2
Zhao, X1
Kung, TFC1
Wilkinson, CM1
Dirks, CA1
Jickling, GC1
Colbourne, F1
Ma, M1
Chai, K1
Deng, R1
Jhuo, SJ1
Liu, IH1
Tasi, WC1
Chou, TW1
Lin, YH1
Wu, BN1
Lee, KT1
Lai, WT1
Lin, Z3
Huang, H1
Gu, Y3
Huang, K3
Hu, Y4
Ji, Z3
Wang, S4
Yang, T1
Pan, S3
Sexton, SJ2
Govada, V1
Babik, B1
Balogh, AL1
Sudy, R1
Ivankovitsne-Kiss, O1
Fodor, GH1
Petak, F1
Nakayama, S1
Taguchi, N1
Isaka, Y1
Nakamura, T1
Tanaka, M1
Loos, JA1
Churio, MS1
Cumino, AC1
Kuang, Y1
Li, B1
Fan, J1
Qiao, X1
Ye, M1
Bahari, B1
Sun, CJ1
Jin, Y1
Zhang, WY1
Li, L1
Liu, XW1
Molyneaux, BJ1
Jackson, TC1
Wallisch, JS1
Park, SY1
Poloyac, S1
Vagni, VA1
Janesko-Feldman, KL1
Hoshitsuki, K1
Minnigh, MB1
Zhou, F1
Liu, Y1
Yang, B1
Hu, Z1
Chen, H2
Li, Y2
Gu, J1
Yin, L1
Bian, F1
Su, L1
Hong, Y1
Deng, Y1
Chi, W1
Ledig, PD1
Yun, CE1
Hernández-Abad, VJ1
Sánchez-González, EG1
Espinosa-Contreras, C1
Marroquín-Segura, R1
Mora-Guevara, JLA1
Flores-Cabrera, Y1
Kallio-Kujala, IJ1
Bennett, RC1
Raekallio, MR1
Yatkin, E1
Meierjohann, A1
Savontaus, E1
Scheinin, M1
Spillmann, T1
Vainio, OM1
Cobanoglu, MC1
Li, J2
Hidvegi, T1
Hale, P1
Ewing, M1
Chu, AS1
Gong, Z1
Muzumdar, R1
Pak, SC1
Silverman, GA1
Bahar, I1
Perlmutter, DH1
Kuwar, R1
Rolfe, A1
Di, L1
Xu, H1
He, L1
Jiang, Y2
Zhang, S2
Sun, D1
Ding, Y1
Chen, W1
Feng, Y1
Shi, G1
Augusto, PSA1
Braga, AV1
Rodrigues, FF1
Morais, MI1
Dutra, MMGB1
Batista, CRA1
Melo, ISF1
Costa, SOAM1
Goulart, FA1
Coelho, MM2
Machado, RR2
Yamazaki, M1
Avula, UM1
Bandaru, K1
Atreya, A1
Boppana, VS1
Honjo, H1
Kodama, I1
Kamiya, K1
Kalifa, J1
Dutra, MM1
Godin, AM1
César, IC1
Nascimento, EB1
Menezes, RR1
Ferreira, WC1
Soares, DG1
Seniuk, JG1
Araújo, DP1
Bastos, LF1
Pianetti, GA1
de Fátima, Â1
dos Santos, RM1
Oliveira, SM1
Silva, CR1
Hoffmeister, C1
Ferreira, J1
Assreuy, J2
Huang, CW1
Lai, MC1
Cheng, JT1
Tsai, JJ1
Huang, CC1
Wu, SN1
de Santana, MT1
de Oliveira, MG1
Santana, MF1
De Sousa, DP1
Santana, DG1
Camargo, EA1
de Oliveira, AP1
Almeida, JR1
Quintans-Júnior, LJ2
Popovich, PG2
Tsymbalyuk, O7
Caridi, J2
Gullapalli, RP1
Kilbourne, MJ1
Kerur, N1
Hirano, Y1
Tarallo, V1
Fowler, BJ1
Bastos-Carvalho, A1
Yasuma, T1
Yasuma, R1
Kim, Y1
Hinton, DR1
Kirschning, CJ1
Gelfand, BD1
Ambati, J1
Boyda, HN1
Procyshyn, RM1
Asiri, Y1
Wu, C1
Wang, CK1
Lo, R1
Pang, CC1
Honer, WG1
Barr, AM1
Koh, GC1
Weehuizen, TA1
Breitbach, K1
Krause, K1
de Jong, HK1
Kager, LM1
Hoogendijk, AJ1
Bast, A1
Peacock, SJ1
van der Poll, T1
Steinmetz, I1
Wiersinga, WJ1
Vollmer, C2
Weiß, S1
Beck, C2
Bauer, I2
Picker, O2
Luppi, P1
Drain, P1
Xia, H1
Zhang, D1
Yang, S1
Xu, L1
Wu, J1
Ren, J1
Yao, W1
Fan, L1
Tian, Y1
Pan, HL1
Wang, X1
Alexandre, J1
Puddu, PE1
Simard, C1
Hof, T1
Sallé, L1
Guinamard, R1
Manrique, A1
Rouet, R1
Beygui, F1
Milliez, P1
da Costa, AV1
Calábria, LK1
de Souza Santos, P1
Goulart, LR1
Espindola, FS1
Zweckberger, K1
Hackenberg, K1
Jung, CS1
Hertle, DN1
Kiening, KL1
Unterberg, AW1
Sakowitz, OW1
Brereton, MF1
Iberl, M1
Shimomura, K1
Zhang, Q2
Adriaenssens, AE1
Proks, P1
Spiliotis, II1
Dace, W1
Mattis, KK1
Ramracheya, R1
Gribble, FM1
Reimann, F1
Clark, A1
Rorsman, P1
Ashcroft, FM1
Li, DJ1
Huang, F1
Lu, WJ1
Jiang, GJ1
Deng, YP1
Shen, FM1
Roche, C1
Besnier, M1
Cassel, R1
Harouki, N1
Coquerel, D1
Guerrot, D1
Nicol, L1
Loizon, E1
Remy-Jouet, I1
Morisseau, C1
Mulder, P1
Ouvrard-Pascaud, A1
Madec, AM1
Richard, V1
Bellien, J1
Barthel, F1
Hahn, AM1
Herminghaus, A1
Schäfer, S1
Li, X2
Xie, Z2
Boudjelal, A1
Siracusa, L1
Henchiri, C1
Sarri, M1
Abderrahim, B1
Baali, F1
Ruberto, G1
Hosier, H1
Peterson, D1
Keledjian, K3
Smith, BR1
Ivanova, S7
Ahmad, A1
Khan, RM1
Alkharfy, KM1
Raish, M1
Al-Jenoobi, FI1
Al-Mohizea, AM1
Jameel, MN1
Xiong, Q1
Mansoor, A1
Bache, RJ2
Zhang, J1
Shafaroodi, H3
Barati, S1
Almasirad, A1
Moezi, L1
Xu, ZM1
Yuan, F1
Liu, YL1
Ding, J1
Tian, HL1
de Lacerda Neto, LJ1
Ramos, AG1
Santos Sales, V1
de Souza, SD1
Dos Santos, AT1
de Oliveira, LR1
Kerntopf, MR1
de Albuquerque, TR1
Coutinho, HD1
Wanderley, AG1
de Menezes, IR1
Wu, D2
Ren, P1
Zheng, Y1
Zhang, L1
Xu, G1
Xie, W1
Lloyd, EE1
Curci, JA1
Coselli, JS1
Milewicz, DM1
Shen, YH1
LeMaire, SA1
Xue, W1
Zhang, M1
Niu, L1
Liang, Y1
Yang, Y1
Zhang, XJ1
Yin, J1
Li, LT1
Ye, Y1
Lin, Y1
Perez-Polo, JR1
Birnbaum, Y2
Zhao, JL2
Yang, YJ2
Pei, WD2
Sun, YH2
Zhai, M2
Liu, YX1
Gao, RL2
Wallace, JL1
Vong, L1
McKnight, W1
Dicay, M1
Martin, GR1
Kilbourne, M1
Tosun, C2
Bochicchio, G1
Karimollah, AR1
Gholipour, T1
Nezami, BG1
Ebrahimi, F2
Rodrigues, Pde A1
de Morais, SM1
de Souza, CM1
Silva, AR1
de Andrade, GM1
Silva, MG1
Albuquerque, RL1
Rao, VS2
Santos, FA2
Tsymbalyuk, N2
Yurovsky, V1
Li, Q1
Li, XL1
Bao, JM1
Shen, XH1
Woo, SK3
Norenberg, MD1
Chen, Z2
Bryan, J1
Landsman, D1
Al-Azzam, SI1
Abdul-Razzak, KK1
Jaradat, MW1
Nnamani, PO1
Attama, AA1
Ibezim, EC1
Adikwu, MU1
Zhou, L1
Zhang, Y1
Hebert, MF1
Unadkat, JD1
Mao, Q1
Baraka, A1
ElGhotny, S1
Berwick, ZC1
Payne, GA1
Lynch, B1
Dick, GM1
Sturek, M1
Tune, JD1
Patel, AD1
Geng, Z3
Saxena, B1
Krishnamurthy, S1
Singh, S1
Chen, B1
Moore, A1
Escobedo, LV1
Koletsky, MS1
Hou, D1
Koletsky, RJ1
Ernsberger, P1
Suto, Y1
Oshima, K1
Arakawa, K1
Sato, H1
Yamazaki, H1
Matsumoto, K1
Takeyoshi, I1
Adeneye, AA1
Agbaje, EO1
Olagunju, JA1
Revermann, M1
Schloss, M1
Mieth, A1
Babelova, A1
Schröder, K1
Neofitidou, S1
Buerkl, J1
Kirschning, T1
Schermuly, RT1
Hofstetter, C1
Brandes, RP1
Fakhfouri, G1
Rahimian, R1
Hashemi, S1
Rasouli, MR1
Bahremand, A1
Mehr, SE1
Khorramizadeh, MR1
El-Hashim, AZ1
Edafiogho, IO1
Jaffal, SM1
Yousif, MH1
Ezeamuzie, CI1
Kombian, SB1
Xiang, L1
Lu, S1
Fuller, W1
Aneja, A1
Russell, GV1
Jones, LB1
Hester, R1
Nakaizumi, A1
Puro, DG1
Kwon, MS1
Ivanov, A3
Bhatta, S3
Romero, TR1
Duarte, ID1
Tator, CH1
Hashimoto, R1
Raich, A1
Norvell, D1
Fehlings, MG1
Harrop, JS1
Guest, J1
Aarabi, B1
Grossman, RG1
Afify, EA1
Khedr, MM1
Omar, AG1
Nasser, SA1
Kim, SJ1
Zhang, H2
Khaliulin, I1
Choisy, SC1
Bond, R1
Lin, H1
El Haou, S1
Milnes, JT1
Hancox, JC1
Suleiman, MS1
James, AF1
Lv, Y1
Ren, Y1
Sun, L1
Wei, M1
Jia, D1
Mathias, R1
von der Weid, PY1
Brandão, MS1
Pereira, SS1
Lima, DF1
Oliveira, JP1
Ferreira, EL1
Chaves, MH1
Almeida, FR1
Zhao, KS1
Huang, X1
Liu, J1
Huang, Q1
Jin, C1
Jin, J1
Zhao, G1
Genda, S1
Miura, T1
Miki, T2
Ichikawa, Y1
Shimamoto, K1
Shioiri, H1
Komaru, T1
Sato, K1
Takahashi, K1
Takeda, S1
Kanatsuka, H1
Watanabe, J1
Shirato, K1
Zheng, S1
Zuo, Z1
Maslov, LN1
Lishmanov, YB1
Solenkova, NV1
Gross, GJ4
Stefano, GB1
Tam, SW1
Kamalakkannan, N1
Prince, PS1
Virdi, J1
Sivakami, S1
Shahani, S1
Suthar, AC1
Banavalikar, MM1
Biyani, MK1
Zhu, BM1
Miyamoto, S1
Nagasawa, Y1
Wajima, T1
Hashimoto, K1
Rahgozar, M1
Willgoss, DA1
Gobé, GC1
Endre, ZH1
Jiang, K1
Zhao, Z1
Shui, Q1
Xia, Z1
Callera, GE1
Yeh, E1
Tostes, RC1
Caperuto, LC1
Carvalho, CR1
Bendhack, LM1
Tavackoli, S1
Ashitkov, T1
Hu, ZY1
Motamedi, M1
Uretsky, BF1
Rajesh, KG1
Sasaguri, S1
Suzuki, R1
Xing, Y1
Maeda, H1
Gendron, ME1
Thorin, E1
Perrault, LP1
Ghosh, M1
Hanna, ST1
Wang, R1
McNeill, JR1
Rajasekaran, S1
Sivagnanam, K1
Subramanian, S1
Sy, GY1
Cissé, A2
Nongonierma, RB1
Sarr, M1
Mbodj, NA1
Faye, B3
Ndiaye, A1
Lopez-Sall, P1
Seck, F1
Pompermayer, K1
Souza, DG1
Lara, GG1
Silveira, KD1
Cassali, GD1
Andrade, AA1
Bonjardim, CA1
Passaglio, KT1
Cunha, FQ1
Vieira, MA1
Teixeira, MM1
Jeferson, FA1
Santos, CC1
Silveira, ER1
Hunt, MJ1
Morton, AJ1
Fiorucci, S1
Antonelli, E1
Mencarelli, A1
Orlandi, S1
Renga, B1
Rizzo, G1
Distrutti, E1
Shah, V1
Morelli, A1
Chen, M1
Tarasov, KV1
Melnitchenko, L1
West, GA1
Nalamolu, KR1
Nammi, S1
Iskit, AB1
Erkent, U1
Ertunc, M1
Guc, MO1
Ilhan, M1
Onur, R1
Gilani, AH2
Khan, AU2
Ghayur, MN1
Ali, SF1
Herzig, JW1
Ameen, N1
Melvin, JE1
Vidyasagar, S1
Strande, JL1
Hsu, A1
Su, J1
Fu, X1
Baker, JE1
Traverse, JH1
Chen, Y2
Hou, M1
Donato, M1
D'Annunzio, V1
Berg, G1
Gonzalez, G1
Schreier, L1
Morales, C1
Wikinski, RL1
Gelpi, RJ1
Asadi, S1
Sadeghipour, H1
Tavakoli, S1
Hajrasouliha, AR1
Shi, YX1
Zhu, YZ1
Huang, GY1
Moore, PK2
Huang, SH1
Yao, T1
Zhu, YC1
Birkenmeier, K1
Staudt, A1
Schunck, WH1
Janke, I1
Labitzke, C1
Prange, T1
Trimpert, C1
Krieg, T1
Landsberger, M1
Stangl, V1
Felix, SB1
Chen, X2
Pan, TT1
Neo, KL1
Lee, SW1
Khin, ES1
Bian, JS1
Lee, TM1
Lin, MS1
Chang, NC1
Patel, K1
Connors, SG1
Mendonca, M1
Welch, WJ1
Wilcox, CS1
Lapi, D1
Marchiafava, PL1
Colantuoni, A1
Zhang, YH1
Colantuono, G1
Tiravanti, EA1
Di Venosa, N1
Cazzato, A1
Rastaldo, R1
Cagiano, R1
D'Agostino, D1
Federici, A1
Fiore, T1
Medeiros, JV1
Gadelha, GG1
Lima, SJ1
Garcia, JA1
Soares, PM1
Santos, AA1
Brito, GA1
Ribeiro, RA1
Souza, MH1
Nakagawa, M1
Hori, S1
Adachi, T1
Miyazaki, K1
Inoue, S1
Suzuki, M2
Mori, H1
Nakazawa, H1
Aikawa, N1
Ogawa, S2
Mozaffari, MS1
Schaffer, SW1
Lee, SH1
Yang, MK1
Lim, JH1
Seo, HW1
Yi, KY1
Yoo, SE1
Lee, BH1
Won, HS1
Lee, CS1
Choi, WS1
Shin, HS1
Ferdinandy, P1
Koltai, M1
Dux, L1
Wong, J1
Vanderford, PA1
Winters, J1
Soifer, SJ1
Fineman, JR1
Friedrichs, GS1
Chi, L1
Green, AL1
Lucchesi, BR1
Moritani, K1
Miyazaki, T1
Miyoshi, S1
Asanagi, M1
Zhao, LS1
Mitamura, H1
Nakai, T1
Ichihara, K2
Yao, Z1
Kamigaki, M1
Abiko, Y1
Auchampach, JA1
Maruyama, M1
Toombs, CF1
McGee, DS1
Johnston, WE1
Vinten-Johansen, J1
Fralix, TA1
Steenbergen, C1
London, RE1
Murphy, E1
Tan, HL1
Mazón, P1
Verberne, HJ1
Sleeswijk, ME1
Coronel, R1
Opthof, T1
Janse, MJ1
Hide, EJ1
Piper, J1
Thiemermann, C1
Szabó, C1
Salzman, AL1
Lawton, JS1
Hsia, PW1
Allen, CT1
Damiano, RJ1
Baczkó, I1
Leprán, I1
Papp, JG1
Okada, H1
Kobayashi, S1
Ikeda, T1
Viau, S1
Fontaine, E1
Véronneau, M1
Jasmin, G1
Dumont, L1
Armstead, WM1
Bouskela, E1
Cyrino, FZ1
Conde, CM1
Garcia, AA1
Izumi, H1
Kawahara, J1
Takeuchi, A1
Izawa, T1
Ogawa, N1
Hebbar, L1
Houck, WV1
Zellner, JL1
Dorman, BH1
Spinale, FG1
Onoue, H1
Katusic, ZS1
Plamondon, H1
Blondeau, N1
Heurteaux, C1
Lazdunski, M1
Morita, K1
Kamei, J1
Kim, CD1
Kim, HH1
Kim, YK1
Kwak, YK1
Kim, S1
Yoo, S1
Hong, KW1
Hoyer, S1
Lee, SK1
Löffler, T1
Schliebs, R1
Ambalavanan, N1
Bulger, A1
Ware, J1
Philips, J1
Patel, HM1
Santani, DD1
Goswami, SG1
Hamada, Y1
Ikegami, H1
Ueda, H1
Kawaguchi, Y1
Yamato, E1
Nojima, K1
Yamada, K1
Babaya, N1
Shibata, M1
Ogihara, T1
Shibasaki, T1
Uemura, H1
Sato, T1
Yamaguchi, K1
Koseki, H1
Iwanaga, T1
Nakaya, H1
Seino, S1
Fukuse, T1
Hirata, T1
Omasa, M1
Wada, H1
Valdés, M1
Pascual Leone, A1
O'Connor, C1
Gwilt, M1
Henderson, CG1
Orme, J1
Rourke, JD1
Kamijo, T1
Tomaru, T1
Miwa, A1
Nakamura, F1
Kido, H1
Sugimoto, T1
Uchida, Y1
Lorch, E1
Gey, KF1
Sommer, P1

Reviews

2 reviews available for glyburide and Disease Models, Animal

ArticleYear
Found in translation: The rationale behind the early development of glibenclamide in large hemispheric infarction.
    Neuroscience letters, 2020, 01-18, Volume: 716

    Topics: Animals; Brain Edema; Cerebral Infarction; Disease Models, Animal; Glyburide; Humans

2020
Translational potential of preclinical trials of neuroprotection through pharmacotherapy for spinal cord injury.
    Journal of neurosurgery. Spine, 2012, Volume: 17, Issue:1 Suppl

    Topics: Animals; Disease Models, Animal; Glyburide; Humans; Magnesium Sulfate; Minocycline; Neuroprotective

2012

Trials

2 trials available for glyburide and Disease Models, Animal

ArticleYear
Effects of dexmedetomidine and MK-467 on plasma glucose, insulin and glucagon in a glibenclamide-induced canine hypoglycaemia model.
    Veterinary journal (London, England : 1997), 2018, Volume: 242

    Topics: Adrenergic alpha-2 Receptor Agonists; Anesthesia, Intravenous; Animals; Blood Glucose; Cross-Over St

2018
Levosimendan attenuates pulmonary vascular remodeling.
    Intensive care medicine, 2011, Volume: 37, Issue:8

    Topics: Airway Remodeling; Animals; Cardiotonic Agents; Disease Models, Animal; Germany; Glyburide; Hydrazon

2011

Other Studies

184 other studies available for glyburide and Disease Models, Animal

ArticleYear
Synthesis, in vitro and computational studies of protein tyrosine phosphatase 1B inhibition of a small library of 2-arylsulfonylaminobenzothiazoles with antihyperglycemic activity.
    Bioorganic & medicinal chemistry, 2009, May-01, Volume: 17, Issue:9

    Topics: Animals; Benzothiazoles; Blood Glucose; Computer Simulation; Diabetes Mellitus, Experimental; Diabet

2009
Synthesis, in vitro and in silico studies of a PPARγ and GLUT-4 modulator with hypoglycemic effect.
    Bioorganic & medicinal chemistry letters, 2014, Sep-15, Volume: 24, Issue:18

    Topics: Animals; Diabetes Mellitus, Experimental; Disease Models, Animal; Glucose Transporter Type 4; Humans

2014
Discovery of novel pyrrole-based scaffold as potent and orally bioavailable free fatty acid receptor 1 agonists for the treatment of type 2 diabetes.
    Bioorganic & medicinal chemistry, 2016, May-01, Volume: 24, Issue:9

    Topics: Administration, Oral; Animals; Biological Availability; Diabetes Mellitus, Type 2; Disease Models, A

2016
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
    Science translational medicine, 2019, 07-10, Volume: 11, Issue:500

    Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, S

2019
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr

2020
Astaxanthin engages the l-arginine/NO/cGMP/KATP channel signaling pathway toward antinociceptive effects.
    Behavioural pharmacology, 2021, 12-01, Volume: 32, Issue:8

    Topics: Analgesics; Animals; Arginine; Cyclic GMP; Disease Models, Animal; Dose-Response Relationship, Drug;

2021
Glibenclamide promoted functional recovery following sciatic nerve injury in male Wistar rats.
    Fundamental & clinical pharmacology, 2022, Volume: 36, Issue:6

    Topics: Animals; Disease Models, Animal; Glyburide; Male; Quality of Life; Rats; Rats, Wistar; Recovery of F

2022
Neuroprotective effects of Lasmiditan and Sumatriptan in an experimental model of post-stroke seizure in mice: Higher effects with concurrent opioid receptors or K
    Toxicology and applied pharmacology, 2022, 11-01, Volume: 454

    Topics: Adenosine Triphosphate; Animals; Anticonvulsants; bcl-2-Associated X Protein; Benzamides; Disease Mo

2022
Precision Effects of Glibenclamide on MRI Endophenotypes in Clinically Relevant Murine Traumatic Brain Injury.
    Critical care medicine, 2023, 02-01, Volume: 51, Issue:2

    Topics: Animals; Bayes Theorem; Brain Contusion; Brain Edema; Brain Injuries; Brain Injuries, Traumatic; Dis

2023
NLRP3 inflammasome inhibitor glyburide expedites diabetic-induced impaired fracture healing.
    Immunobiology, 2019, Volume: 224, Issue:6

    Topics: Animals; Bony Callus; Cytokines; Diabetes Complications; Disease Models, Animal; Femur; Fracture Hea

2019
Glibenclamide mitigates cognitive impairment and hippocampal neuroinflammation in rats with type 2 diabetes and sporadic Alzheimer-like disease.
    Behavioural brain research, 2020, 02-03, Volume: 379

    Topics: Alzheimer Disease; Animals; Cognitive Dysfunction; Diabetes Complications; Diabetes Mellitus, Type 2

2020
Glibenclamide reverses cardiovascular abnormalities of Cantu syndrome driven by KATP channel overactivity.
    The Journal of clinical investigation, 2020, 03-02, Volume: 130, Issue:3

    Topics: Animals; Cardiomegaly; Disease Models, Animal; Gene Knock-In Techniques; Glyburide; Humans; Hypertri

2020
Cyclophosphamide-induced cystitis results in NLRP3-mediated inflammation in the hippocampus and symptoms of depression in rats.
    American journal of physiology. Renal physiology, 2020, 02-01, Volume: 318, Issue:2

    Topics: Affect; Animals; Antidepressive Agents; Behavior, Animal; Blood-Brain Barrier; Caspase 1; Cyclophosp

2020
Neuroprotection of Glibenclamide against Brain Injury after Cardiac Arrest via Modulation of NLRP3 Inflammasome.
    Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, 2019, Volume: 2019

    Topics: Animals; Brain Injuries; Cardiopulmonary Resuscitation; Disease Models, Animal; Glyburide; Heart Arr

2019
Psychotropic Effects of a New Pyrazolo[C]Pyridine Derivate GIZh-72 are Related to Functional Activity of Atp-Sensitive Potassium Channels.
    Bulletin of experimental biology and medicine, 2020, Volume: 168, Issue:4

    Topics: Animals; Anti-Anxiety Agents; Blood Glucose; Disease Models, Animal; Dose-Response Relationship, Dru

2020
Retinoprotection by BGP-15, a Hydroximic Acid Derivative, in a Type II Diabetic Rat Model Compared to Glibenclamide, Metformin, and Pioglitazone.
    International journal of molecular sciences, 2020, Mar-19, Volume: 21, Issue:6

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Models, Animal; Ele

2020
NEK7 mediated assembly and activation of NLRP3 inflammasome downstream of potassium efflux in ventilator-induced lung injury.
    Biochemical pharmacology, 2020, Volume: 177

    Topics: Animals; Anti-Inflammatory Agents; Biomechanical Phenomena; Cations, Monovalent; Cell Line; Disease

2020
Glibenclamide modulates microglial function and attenuates Aβ deposition in 5XFAD mice.
    European journal of pharmacology, 2020, Oct-05, Volume: 884

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Anti-Inflammatory

2020
Glibenclamide treatment prevents depressive-like behavior and memory impairment induced by chronic unpredictable stress in female mice.
    Behavioural pharmacology, 2021, 04-01, Volume: 32, Issue:2&3

    Topics: Animals; Behavior, Animal; Depression; Disease Models, Animal; Female; Glyburide; Hippocampus; Hypog

2021
Continuous Glibenclamide Prevents Hemorrhagic Transformation in a Rodent Model of Severe Ischemia-Reperfusion.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2021, Volume: 30, Issue:3

    Topics: Animals; Brain Edema; Disease Models, Animal; Fibrinolytic Agents; Glyburide; Infarction, Middle Cer

2021
Inhibition of NLRP3 inflammasome by glibenclamide attenuated dopaminergic neurodegeneration and motor deficits in paraquat and maneb-induced mouse Parkinson's disease model.
    Toxicology letters, 2021, Oct-01, Volume: 349

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Antiparkinson Agents; Disease Models, Animal; Dopam

2021
Glibenclamide does not improve outcome following severe collagenase-induced intracerebral hemorrhage in rats.
    PloS one, 2021, Volume: 16, Issue:6

    Topics: Animals; Behavior, Animal; Blood-Brain Barrier; Brain Edema; Cerebral Hemorrhage; Collagenases; Dise

2021
Study of the correlation between the noncanonical pathway of pyroptosis and idiopathic inflammatory myopathy.
    International immunopharmacology, 2021, Volume: 98

    Topics: Animals; Disease Models, Animal; Female; Glyburide; Guinea Pigs; Humans; Mice; Muscle, Skeletal; Myo

2021
Characteristics of Ventricular Electrophysiological Substrates in Metabolic Mice Treated with Empagliflozin.
    International journal of molecular sciences, 2021, Jun-05, Volume: 22, Issue:11

    Topics: Animals; Benzhydryl Compounds; Cardiovascular Diseases; Connexin 43; Connexins; Diet, High-Fat; Dise

2021
Glibenclamide ameliorates cerebral edema and improves outcomes in a rat model of status epilepticus.
    Neuropharmacology, 2017, Jul-15, Volume: 121

    Topics: Animals; Blood-Brain Barrier; Brain; Brain Edema; Cognition Disorders; Disease Models, Animal; Gene

2017
Bladder fibrosis during outlet obstruction is triggered through the NLRP3 inflammasome and the production of IL-1β.
    American journal of physiology. Renal physiology, 2017, 09-01, Volume: 313, Issue:3

    Topics: Animals; Autocrine Communication; Cells, Cultured; Disease Models, Animal; Female; Fibrillar Collage

2017
Levosimendan prevents bronchoconstriction and adverse respiratory tissue mechanical changes in rabbits.
    American journal of physiology. Lung cellular and molecular physiology, 2017, Nov-01, Volume: 313, Issue:5

    Topics: Airway Resistance; Animals; Bronchial Hyperreactivity; Bronchoconstriction; Cardiac Output; Disease

2017
Glibenclamide and Therapeutic Hypothermia Have Comparable Effect on Attenuating Global Cerebral Edema Following Experimental Cardiac Arrest.
    Neurocritical care, 2018, Volume: 29, Issue:1

    Topics: Animals; Brain Edema; Disease Models, Animal; Glyburide; Heart Arrest; Hypoglycemic Agents; Hypother

2018
Anthelminthic activity of glibenclamide on secondary cystic echinococcosis in mice.
    PLoS neglected tropical diseases, 2017, Volume: 11, Issue:11

    Topics: Administration, Oral; Animals; Anthelmintics; Disease Models, Animal; Echinococcosis; Echinococcus g

2017
Antitussive and expectorant activities of licorice and its major compounds.
    Bioorganic & medicinal chemistry, 2018, 01-01, Volume: 26, Issue:1

    Topics: Administration, Oral; Ammonia; Animals; Antitussive Agents; Cough; Disease Models, Animal; Dose-Resp

2018
ATP-sensitive potassium-channel inhibitor glibenclamide attenuates HPA axis hyperactivity, depression- and anxiety-related symptoms in a rat model of Alzheimer's disease.
    Brain research bulletin, 2018, Volume: 137

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Anxiety; Corticosterone; Depression; Disease Mode

2018
Role of AKR1C3 in renal injury and glibenclamide is anti-inflammatory in preeclamptic rats.
    Gene, 2018, Jul-01, Volume: 662

    Topics: Acute Kidney Injury; Aldo-Keto Reductase Family 1 Member C3; Animals; Anti-Inflammatory Agents; Dise

2018
Glibenclamide Produces Region-Dependent Effects on Cerebral Edema in a Combined Injury Model of Traumatic Brain Injury and Hemorrhagic Shock in Mice.
    Journal of neurotrauma, 2018, 09-01, Volume: 35, Issue:17

    Topics: Animals; Blood Glucose; Brain Edema; Brain Injuries, Traumatic; Disease Models, Animal; Glyburide; H

2018
Neuroprotective potential of glibenclamide is mediated by antioxidant and anti-apoptotic pathways in intracerebral hemorrhage.
    Brain research bulletin, 2018, Volume: 142

    Topics: Animals; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Brain; Caspase 3; Cerebral Hemorrhage;

2018
TLR4-MyD88 pathway promotes the imbalanced activation of NLRP3/NLRP6 via caspase-8 stimulation after alkali burn injury.
    Experimental eye research, 2018, Volume: 176

    Topics: Animals; Blotting, Western; Burns, Chemical; Caspase 8; Disease Models, Animal; Eye Injuries; Fluore

2018
Bladder decompensation and reduction in nerve density in a rat model of chronic bladder outlet obstruction are attenuated with the NLRP3 inhibitor glyburide.
    American journal of physiology. Renal physiology, 2019, 01-01, Volume: 316, Issue:1

    Topics: Animals; Anti-Inflammatory Agents; Autonomic Nervous System; Chronic Disease; Cystitis; Disease Mode

2019
Controlled release of glibenclamide from monolithic silica subdermal implants produced by the sol-gel process and its use for hyperglycaemia treatment in a murine model.
    Materials science & engineering. C, Materials for biological applications, 2019, Jan-01, Volume: 94

    Topics: Animals; Delayed-Action Preparations; Disease Models, Animal; Glyburide; Humidity; Hyperglycemia; Im

2019
An analog of glibenclamide selectively enhances autophagic degradation of misfolded α1-antitrypsin Z.
    PloS one, 2019, Volume: 14, Issue:1

    Topics: alpha 1-Antitrypsin; alpha 1-Antitrypsin Deficiency; Animals; Autophagy; Caenorhabditis elegans; Cae

2019
A novel small molecular NLRP3 inflammasome inhibitor alleviates neuroinflammatory response following traumatic brain injury.
    Journal of neuroinflammation, 2019, Apr-11, Volume: 16, Issue:1

    Topics: Analysis of Variance; Animals; Brain Injuries, Traumatic; CD11b Antigen; Disease Models, Animal; Dos

2019
Glibenclamide alleviates inflammation in oleic acid model of acute lung injury through NLRP3 inflammasome signaling pathway.
    Drug design, development and therapy, 2019, Volume: 13

    Topics: Acute Lung Injury; Animals; Disease Models, Animal; Glyburide; Inflammasomes; Inflammation; Male; NL

2019
Metformin antinociceptive effect in models of nociceptive and neuropathic pain is partially mediated by activation of opioidergic mechanisms.
    European journal of pharmacology, 2019, Sep-05, Volume: 858

    Topics: Analgesics; Animals; Disease Models, Animal; Female; Glyburide; Hyperalgesia; Metformin; Mice; Naltr

2019
Acute regional left atrial ischemia causes acceleration of atrial drivers during atrial fibrillation.
    Heart rhythm, 2013, Volume: 10, Issue:6

    Topics: Animals; Atrial Fibrillation; Disease Models, Animal; Electrophysiologic Techniques, Cardiac; Glybur

2013
Activity of nicorandil, a nicotinamide derivative with a nitrate group, in the experimental model of pain induced by formaldehyde in mice.
    Pharmacology, biochemistry, and behavior, 2013, Volume: 106

    Topics: Analgesics; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Formaldehyde; Glyburi

2013
Anti-nociceptive and anti-edematogenic effects of glibenclamide in a model of acute gouty attack in rats.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2013, Volume: 62, Issue:6

    Topics: Analgesics; Animals; Anti-Inflammatory Agents; Dinoprostone; Disease Models, Animal; Glyburide; Gout

2013
Pregabalin attenuates excitotoxicity in diabetes.
    PloS one, 2013, Volume: 8, Issue:6

    Topics: Adenosine Triphosphate; Animals; Anticonvulsants; Blood Glucose; Cell Line; Diabetic Neuropathies; D

2013
Citronellal, a monoterpene present in Java citronella oil, attenuates mechanical nociception response in mice.
    Pharmaceutical biology, 2013, Volume: 51, Issue:9

    Topics: Acyclic Monoterpenes; Aldehydes; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclic GMP; Cymbo

2013
MRI evidence that glibenclamide reduces acute lesion expansion in a rat model of spinal cord injury.
    Spinal cord, 2013, Volume: 51, Issue:11

    Topics: Aging; Animals; Disease Models, Animal; Female; Glyburide; Hemorrhage; Magnetic Resonance Imaging; R

2013
TLR-independent and P2X7-dependent signaling mediate Alu RNA-induced NLRP3 inflammasome activation in geographic atrophy.
    Investigative ophthalmology & visual science, 2013, Nov-11, Volume: 54, Issue:12

    Topics: Alu Elements; Animals; Carrier Proteins; Caspase 1; Disease Models, Animal; Geographic Atrophy; Glyb

2013
Antidiabetic-drug combination treatment for glucose intolerance in adult female rats treated acutely with olanzapine.
    Progress in neuro-psychopharmacology & biological psychiatry, 2014, Jan-03, Volume: 48

    Topics: Animals; Benzodiazepines; Disease Models, Animal; Drug Therapy, Combination; Fasting; Female; Glucos

2014
Glyburide reduces bacterial dissemination in a mouse model of melioidosis.
    PLoS neglected tropical diseases, 2013, Volume: 7, Issue:10

    Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Burkholderia pseudomallei; Ceftazidime; Di

2013
Hypothermia improves oral and gastric mucosal oxygenation during hypoxic challenges.
    British journal of anaesthesia, 2014, Volume: 113, Issue:3

    Topics: Animals; Cardiac Output; Cardiotonic Agents; Cross-Over Studies; Disease Models, Animal; Dogs; Femal

2014
Autocrine C-peptide mechanism underlying INS1 beta cell adaptation to oxidative stress.
    Diabetes/metabolism research and reviews, 2014, Volume: 30, Issue:7

    Topics: Adaptation, Physiological; Animals; Apoptosis; Autocrine Communication; C-Peptide; Cell Line, Tumor;

2014
Role of ATP-sensitive potassium channels in modulating nociception in rat model of bone cancer pain.
    Brain research, 2014, Mar-20, Volume: 1554

    Topics: Animals; Bone Neoplasms; Cell Line, Tumor; Disease Models, Animal; Female; Glyburide; Hyperalgesia;

2014
Proarrhythmic effects of aldosterone during myocardial ischemia-reperfusion: implication of the sarcolemmal-KATP channels.
    Journal of cardiovascular pharmacology, 2014, Volume: 64, Issue:2

    Topics: Action Potentials; Aldosterone; Animals; Benzopyrans; Dihydropyridines; Disease Models, Animal; Fema

2014
Glibenclamide treatment modulates the expression and localization of myosin-IIB in diabetic rat brain.
    Journal of the neurological sciences, 2014, May-15, Volume: 340, Issue:1-2

    Topics: Animals; Diabetes Mellitus, Experimental; Disease Models, Animal; Gene Expression Regulation; Glybur

2014
Glibenclamide reduces secondary brain damage after experimental traumatic brain injury.
    Neuroscience, 2014, Jul-11, Volume: 272

    Topics: Animals; Brain Edema; Brain Injuries; Disease Models, Animal; Electroencephalography; Glyburide; Int

2014
Reversible changes in pancreatic islet structure and function produced by elevated blood glucose.
    Nature communications, 2014, Aug-22, Volume: 5

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Disease Models, Animal; Electrophysiology;

2014
Metformin promotes irisin release from murine skeletal muscle independently of AMP-activated protein kinase activation.
    Acta physiologica (Oxford, England), 2015, Volume: 213, Issue:3

    Topics: AMP-Activated Protein Kinases; Animals; Biomarkers; Blood Glucose; Cells, Cultured; Diabetes Mellitu

2015
Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice.
    American journal of physiology. Heart and circulatory physiology, 2015, May-01, Volume: 308, Issue:9

    Topics: Animals; Benzoates; Blood Glucose; Coronary Vessels; Disease Models, Animal; Dose-Response Relations

2015
The beneficial effects of acute hypercapnia on microcirculatory oxygenation in an animal model of sepsis are independent of K(+)ATP channels.
    Microvascular research, 2015, Volume: 99

    Topics: Adenosine Triphosphate; Animals; Colon; Cytokines; Disease Models, Animal; Glyburide; Hemodynamics;

2015
Glibenclamide Improves Survival and Neurologic Outcome After Cardiac Arrest in Rats.
    Critical care medicine, 2015, Volume: 43, Issue:9

    Topics: Animals; Brain; Chemokine CCL2; Disease Models, Animal; Glyburide; Heart Arrest; Hemodynamics; Male;

2015
Antidiabetic Effects of Aqueous Infusions of Artemisia herba-alba and Ajuga iva in Alloxan-Induced Diabetic Rats.
    Planta medica, 2015, Volume: 81, Issue:9

    Topics: Ajuga; Alloxan; Animals; Apigenin; Artemisia; Blood Glucose; Chlorogenic Acid; Diabetes Mellitus, Ex

2015
A Direct Comparison of Three Clinically Relevant Treatments in a Rat Model of Cervical Spinal Cord Injury.
    Journal of neurotrauma, 2015, Nov-01, Volume: 32, Issue:21

    Topics: Animals; Behavior, Animal; Cervical Cord; Disease Models, Animal; Female; Glyburide; Hypoglycemic Ag

2015
Effects of Thymoquinone on the Pharmacokinetics and Pharmacodynamics of Glibenclamide in a Rat Model.
    Natural product communications, 2015, Volume: 10, Issue:8

    Topics: Animals; Aryl Hydrocarbon Hydroxylases; Benzoquinones; Blood Glucose; Cytochrome P-450 CYP3A; Cytoch

2015
ATP sensitive K(+) channels are critical for maintaining myocardial perfusion and high energy phosphates in the failing heart.
    Journal of molecular and cellular cardiology, 2016, Volume: 92

    Topics: Adenosine Triphosphate; Animals; Coronary Circulation; Disease Models, Animal; Dogs; Glyburide; Hear

2016
A role for ATP-sensitive potassium channels in the anticonvulsant effects of triamterene in mice.
    Epilepsy research, 2016, Volume: 121

    Topics: Analysis of Variance; Animals; Anticonvulsants; Convulsants; Diazoxide; Disease Models, Animal; Dose

2016
Glibenclamide Attenuates Blood-Brain Barrier Disruption in Adult Mice after Traumatic Brain Injury.
    Journal of neurotrauma, 2017, 02-15, Volume: 34, Issue:4

    Topics: Animals; Apoptosis; Blood-Brain Barrier; Brain Injuries, Traumatic; Disease Models, Animal; Glyburid

2017
Glibenclamide Is Comparable to Target Temperature Management in Improving Survival and Neurological Outcome After Asphyxial Cardiac Arrest in Rats.
    Journal of the American Heart Association, 2016, 07-13, Volume: 5, Issue:7

    Topics: Animals; Asphyxia; Cardiopulmonary Resuscitation; Disease Models, Animal; Glyburide; Heart Arrest; H

2016
Gastroprotective and ulcer healing effects of hydroethanolic extract of leaves of Caryocar coriaceum: Mechanisms involved in the gastroprotective activity.
    Chemico-biological interactions, 2017, Jan-05, Volume: 261

    Topics: Animals; Antioxidants; Capsaicin; Chromatography, High Pressure Liquid; Chronic Disease; Disease Mod

2017
NLRP3 (Nucleotide Oligomerization Domain-Like Receptor Family, Pyrin Domain Containing 3)-Caspase-1 Inflammasome Degrades Contractile Proteins: Implications for Aortic Biomechanical Dysfunction and Aneurysm and Dissection Formation.
    Arteriosclerosis, thrombosis, and vascular biology, 2017, Volume: 37, Issue:4

    Topics: Aged; Angiotensin II; Animals; Aorta, Abdominal; Aorta, Thoracic; Aortic Aneurysm, Abdominal; Aortic

2017
Effects of taurine on aortic rings isolated from fructose-fed insulin resistance Sprague-Dawley rat are changed.
    Cardiovascular drugs and therapy, 2008, Volume: 22, Issue:6

    Topics: 4-Aminopyridine; Acetylcholine; Administration, Oral; Animals; Aorta; Blood Glucose; Blood Pressure;

2008
Brain damage related to hemorrhagic transformation following cerebral ischemia and the role of K ATP channels.
    Brain research, 2008, Nov-19, Volume: 1241

    Topics: Adenosine Triphosphatases; Animals; Brain; Brain Edema; Brain Infarction; Brain Ischemia; Cerebral H

2008
Oral glyburide, but not glimepiride, blocks the infarct-size limiting effects of pioglitazone.
    Cardiovascular drugs and therapy, 2008, Volume: 22, Issue:6

    Topics: Administration, Oral; Animals; Body Weight; Coronary Vessels; Data Interpretation, Statistical; Deca

2008
Carvedilol reduces myocardial no-reflow by decreasing endothelin-1 via activation of the ATP-sensitive K+ channel.
    Perfusion, 2008, Volume: 23, Issue:2

    Topics: Animals; Antihypertensive Agents; Carbazoles; Carvedilol; Disease Models, Animal; Endothelin-1; Glyb

2008
Endogenous and exogenous hydrogen sulfide promotes resolution of colitis in rats.
    Gastroenterology, 2009, Volume: 137, Issue:2

    Topics: Analysis of Variance; Animals; Biomarkers; Biopsy, Needle; Colitis; Cyclooxygenase 1; Cyclooxygenase

2009
Key role of sulfonylurea receptor 1 in progressive secondary hemorrhage after brain contusion.
    Journal of neurotrauma, 2009, Volume: 26, Issue:12

    Topics: Animals; ATP-Binding Cassette Transporters; Blood-Brain Barrier; Brain; Brain Hemorrhage, Traumatic;

2009
ATP-sensitive potassium channels contribute to the time-dependent alteration in the pentylenetetrazole-induced seizure threshold in diabetic mice.
    Seizure, 2010, Volume: 19, Issue:1

    Topics: Analysis of Variance; Animals; Blood Glucose; Body Weight; Cromakalim; Diabetes Mellitus, Experiment

2010
Gastroprotective effect of barbatusin and 3-beta-hydroxy-3-deoxibarbatusin, quinonoid diterpenes isolated from Plectranthus grandis, in ethanol-induced gastric lesions in mice.
    Journal of ethnopharmacology, 2010, Feb-17, Volume: 127, Issue:3

    Topics: Acetylcysteine; Animals; Anti-Ulcer Agents; Antioxidants; Capsaicin; Disease Models, Animal; Diterpe

2010
Glibenclamide is superior to decompressive craniectomy in a rat model of malignant stroke.
    Stroke, 2010, Volume: 41, Issue:3

    Topics: Animals; Decompressive Craniectomy; Disease Models, Animal; Glyburide; Male; Rats; Rats, Wistar; Str

2010
Effects of antiallergic herbal agents on cystic fibrosis transmembrane conductance regulator in nasal mucosal epithelia of allergic rhinitis rabbits.
    Chinese medical journal, 2009, Dec-20, Volume: 122, Issue:24

    Topics: Animals; Cells, Cultured; Chemokine CCL2; Chemokine CCL5; Cystic Fibrosis Transmembrane Conductance

2009
Brief suppression of Abcc8 prevents autodestruction of spinal cord after trauma.
    Science translational medicine, 2010, Apr-21, Volume: 2, Issue:28

    Topics: Animals; ATP-Binding Cassette Transporters; Disease Models, Animal; Gene Expression Regulation; Glyb

2010
The nephroprotective effects of pioglitazone and glibenclamide against gentamicin-induced nephrotoxicity in rats: a comparative study.
    Journal of chemotherapy (Florence, Italy), 2010, Volume: 22, Issue:2

    Topics: Animals; Antioxidants; Creatinine; Disease Models, Animal; Gentamicins; Glyburide; Kidney Diseases;

2010
SRMS142-based solid lipid microparticles: application in oral delivery of glibenclamide to diabetic rats.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2010, Volume: 76, Issue:1

    Topics: Administration, Oral; Animals; Ascorbic Acid; Blood Glucose; Calorimetry, Differential Scanning; Che

2010
Increased glyburide clearance in the pregnant mouse model.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:9

    Topics: Animals; Disease Models, Animal; Female; Glyburide; Hypoglycemic Agents; Mice; Pregnancy

2010
Study of the effect of inhibiting galanin in Alzheimer's disease induced in rats.
    European journal of pharmacology, 2010, Sep-01, Volume: 641, Issue:2-3

    Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Animals; Avoidance Learning; Brain;

2010
Contribution of adenosine A(2A) and A(2B) receptors to ischemic coronary dilation: role of K(V) and K(ATP) channels.
    Microcirculation (New York, N.Y. : 1994), 2010, Volume: 17, Issue:8

    Topics: 4-Aminopyridine; Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Anima

2010
Glibenclamide reduces hippocampal injury and preserves rapid spatial learning in a model of traumatic brain injury.
    Journal of neuropathology and experimental neurology, 2010, Volume: 69, Issue:12

    Topics: Animals; Brain Injuries; Disease Models, Animal; Glyburide; Hippocampus; Maze Learning; Rats; Rats,

2010
Gastroprotective potential of risperidone, an atypical antipsychotic, against stress and pyloric ligation induced gastric lesions.
    Chemico-biological interactions, 2011, Apr-25, Volume: 190, Issue:2-3

    Topics: Animals; Antipsychotic Agents; Capillary Permeability; Dinoprostone; Disease Models, Animal; Dopamin

2011
Sitagliptin lowers glucagon and improves glucose tolerance in prediabetic obese SHROB rats.
    Experimental biology and medicine (Maywood, N.J.), 2011, Volume: 236, Issue:3

    Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Disease Models, Animal; Feeding Beha

2011
The effect of nicorandil on small intestinal ischemia-reperfusion injury in a canine model.
    Digestive diseases and sciences, 2011, Volume: 56, Issue:8

    Topics: Animals; Disease Models, Animal; Dogs; Female; Glyburide; Intestine, Small; KATP Channels; Male; Mes

2011
Metformin: an effective attenuator of risperidone-induced insulin resistance hyperglycemia and dyslipidemia in rats.
    Indian journal of experimental biology, 2011, Volume: 49, Issue:5

    Topics: Animals; Antipsychotic Agents; Blood Glucose; Disease Models, Animal; Dyslipidemias; Glyburide; Huma

2011
Sildenafil attenuates TNBS-induced colitis in rats: possible involvement of cGMP and KATP channels.
    Fundamental & clinical pharmacology, 2012, Volume: 26, Issue:2

    Topics: Animals; Colitis; Cyclic GMP; Disease Models, Animal; Glyburide; KATP Channels; Male; Phosphodiester

2012
Anti-tussive and bronchodilator mechanisms of action for the enaminone E121.
    Life sciences, 2011, Sep-12, Volume: 89, Issue:11-12

    Topics: Administration, Inhalation; Adrenergic beta-Antagonists; Airway Obstruction; Aniline Compounds; Anim

2011
Impaired blood pressure recovery to hemorrhage in obese Zucker rats with orthopedic trauma.
    American journal of physiology. Heart and circulatory physiology, 2012, Jan-01, Volume: 302, Issue:1

    Topics: Animals; Arterioles; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Femor

2012
Vulnerability of the retinal microvasculature to hypoxia: role of polyamine-regulated K(ATP) channels.
    Investigative ophthalmology & visual science, 2011, Dec-09, Volume: 52, Issue:13

    Topics: Animals; Apoptosis; Disease Models, Animal; Eflornithine; Glyburide; Hypoxia; Ion Transport; KATP Ch

2011
Sequential activation of hypoxia-inducible factor 1 and specificity protein 1 is required for hypoxia-induced transcriptional stimulation of Abcc8.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2012, Volume: 32, Issue:3

    Topics: Action Potentials; Animals; ATP-Binding Cassette Transporters; Binding Sites; Brain; Calcium Channel

2012
Comparative effects of glibenclamide and riluzole in a rat model of severe cervical spinal cord injury.
    Experimental neurology, 2012, Volume: 233, Issue:1

    Topics: Action Potentials; Analysis of Variance; Animals; Calcimycin; Calcium; Calcium Ionophores; Capillari

2012
N-palmitoyl-ethanolamine (PEA) induces peripheral antinociceptive effect by ATP-sensitive K+-channel activation.
    Journal of pharmacological sciences, 2012, Volume: 118, Issue:2

    Topics: Amides; Analgesics; Animals; Dequalinium; Dinoprostone; Disease Models, Animal; Dose-Response Relati

2012
The involvement of K(ATP) channels in morphine-induced antinociception and hepatic oxidative stress in acute and inflammatory pain in rats.
    Fundamental & clinical pharmacology, 2013, Volume: 27, Issue:6

    Topics: Acute Pain; Analgesics, Opioid; Animals; Chemical and Drug Induced Liver Injury; Diazoxide; Disease

2013
Activation of glibenclamide-sensitive ATP-sensitive K+ channels during β-adrenergically induced metabolic stress produces a substrate for atrial tachyarrhythmia.
    Circulation. Arrhythmia and electrophysiology, 2012, Volume: 5, Issue:6

    Topics: Adrenergic beta-Agonists; Animals; Disease Models, Animal; Electrophysiologic Techniques, Cardiac; G

2012
Protective effect of Na(+)/Ca (2+) exchange blocker KB-R7943 on myocardial ischemia-reperfusion injury in hypercholesterolemic rats.
    Cell biochemistry and biophysics, 2013, Volume: 66, Issue:2

    Topics: Animals; Anti-Arrhythmia Agents; Apoptosis; Diet, High-Fat; Disease Models, Animal; Glyburide; Hemod

2013
Involvement of the NO-cGMP-K(ATP) channel pathway in the mesenteric lymphatic pump dysfunction observed in the guinea pig model of TNBS-induced ileitis.
    American journal of physiology. Gastrointestinal and liver physiology, 2013, Mar-15, Volume: 304, Issue:6

    Topics: Animals; ATP-Binding Cassette Transporters; Disease Models, Animal; Enzyme Inhibitors; Glyburide; Gu

2013
Antinociceptive effect of Lecythis pisonis Camb. (Lecythidaceae) in models of acute pain in mice.
    Journal of ethnopharmacology, 2013, Mar-07, Volume: 146, Issue:1

    Topics: Acetic Acid; Acute Pain; Analgesics; Animals; Arginine; Behavior, Animal; Capsaicin; Disease Models,

2013
New approach to treatment of shock--restitution of vasoreactivity.
    Shock (Augusta, Ga.), 2002, Volume: 18, Issue:2

    Topics: Animals; Blood Pressure; Dimethyl Sulfoxide; Disease Models, Animal; Dopamine; Glyburide; Hemodynami

2002
K(ATP) channel opening is an endogenous mechanism of protection against the no-reflow phenomenon but its function is compromised by hypercholesterolemia.
    Journal of the American College of Cardiology, 2002, Oct-02, Volume: 40, Issue:7

    Topics: Adenosine Triphosphate; Analysis of Variance; Animals; Chronic Disease; Coronary Circulation; Diseas

2002
Impact of hypercholesterolemia on acidosis-induced coronary microvascular dilation.
    Basic research in cardiology, 2003, Volume: 98, Issue:2

    Topics: Acidosis; Animals; Anti-Arrhythmia Agents; Arterioles; Coronary Vessels; Dilatation, Pathologic; Dis

2003
Isoflurane preconditioning reduces purkinje cell death in an in vitro model of rat cerebellar ischemia.
    Neuroscience, 2003, Volume: 118, Issue:1

    Topics: Amino Acid Transport System X-AG; Anesthetics, Inhalation; Animals; Aspartic Acid; Brain Ischemia; C

2003
Activation of peripheral delta opioid receptors eliminates cardiac electrical instability in a rat model of post-infarction cardiosclerosis via mitochondrial ATP-dependent K+ channels.
    Life sciences, 2003, Jul-04, Volume: 73, Issue:7

    Topics: Adenosine Triphosphate; Analgesics, Opioid; Animals; Decanoic Acids; Disease Models, Animal; Drug An

2003
Hypoglycaemic effect of water extracts of Aegle marmelos fruits in streptozotocin diabetic rats.
    Journal of ethnopharmacology, 2003, Volume: 87, Issue:2-3

    Topics: Administration, Oral; Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Disease

2003
Antihyperglycemic effects of three extracts from Momordica charantia.
    Journal of ethnopharmacology, 2003, Volume: 88, Issue:1

    Topics: Alloxan; Animal Structures; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Di

2003
Effect of the sarcolemmal K(ATP) channel blocker HMR1098 on arrhythmias induced by programmed electrical stimulation in canine old myocardial infarction model: comparison with glibenclamide.
    Journal of pharmacological sciences, 2003, Volume: 93, Issue:1

    Topics: Adenosine Triphosphate; Animals; Arrhythmias, Cardiac; Benzamides; Disease Models, Animal; Dogs; Ele

2003
ATP-dependent K+ channels in renal ischemia reperfusion injury.
    Renal failure, 2003, Volume: 25, Issue:6

    Topics: Acute Kidney Injury; Adenosine Triphosphate; Animals; Cromakalim; Diazoxide; Disease Models, Animal;

2003
Electro-acupuncture preconditioning abrogates the elevation of c-Fos and c-Jun expression in neonatal hypoxic-ischemic rat brains induced by glibenclamide, an ATP-sensitive potassium channel blocker.
    Brain research, 2004, Feb-13, Volume: 998, Issue:1

    Topics: Animals; Animals, Newborn; Antihypertensive Agents; Blotting, Western; Brain; Diazoxide; Disease Mod

2004
Changes in the vascular beta-adrenoceptor-activated signalling pathway in 2Kidney-1Clip hypertensive rats.
    British journal of pharmacology, 2004, Volume: 141, Issue:7

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Aorta, Thoracic; Caffeine; Calcium-Transporting ATP

2004
Simvastatin-induced myocardial protection against ischemia-reperfusion injury is mediated by activation of ATP-sensitive K+ channels.
    Coronary artery disease, 2004, Volume: 15, Issue:1

    Topics: Animals; Anti-Arrhythmia Agents; ATP-Binding Cassette Transporters; Collateral Circulation; Disease

2004
Ischemic preconditioning prevents reperfusion heart injury in cardiac hypertrophy by activation of mitochondrial KATP channels.
    International journal of cardiology, 2004, Volume: 96, Issue:1

    Topics: Adenosine Triphosphate; Animals; Cardiomegaly; Decanoic Acids; Disease Models, Animal; Glyburide; He

2004
Loss of endothelial KATP channel-dependent, NO-mediated dilation of endocardial resistance coronary arteries in pigs with left ventricular hypertrophy.
    British journal of pharmacology, 2004, Volume: 143, Issue:2

    Topics: Adenosine Triphosphate; Animals; Bradykinin; Brimonidine Tartrate; Canada; Charybdotoxin; Coronary V

2004
Altered vascular reactivity and KATP channel currents in vascular smooth muscle cells from deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
    Journal of cardiovascular pharmacology, 2004, Volume: 44, Issue:5

    Topics: Adenosine Triphosphate; Animals; Aorta, Thoracic; Blood Pressure; Canada; Cromakalim; Desoxycorticos

2004
Modulatory effects of Aloe vera leaf gel extract on oxidative stress in rats treated with streptozotocin.
    The Journal of pharmacy and pharmacology, 2005, Volume: 57, Issue:2

    Topics: Alkaloids; Aloe; Animals; Anthraquinones; Blood Glucose; Carotenoids; Diabetes Mellitus, Experimenta

2005
Hypoglycaemic and antidiabetic activity of acetonic extract of Vernonia colorata leaves in normoglycaemic and alloxan-induced diabetic rats.
    Journal of ethnopharmacology, 2005, Apr-08, Volume: 98, Issue:1-2

    Topics: Acetone; Administration, Oral; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Disease Mode

2005
[Antidiabetic activity of Zizyphus mauritiana Lam (Rhamnaceae)].
    Dakar medical, 2000, Volume: 45, Issue:2

    Topics: Alloxan; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Disease Models, Animal; Dose-Respo

2000
[Neuron-protective effect of ischemic preconditioning in a rabbit reperfusion model following spinal ischemia].
    [Hokkaido igaku zasshi] The Hokkaido journal of medical science, 2005, Volume: 80, Issue:1

    Topics: Animals; Disease Models, Animal; Glyburide; Ischemic Preconditioning; Male; Neurons; Nicorandil; Pot

2005
The ATP-sensitive potassium channel blocker glibenclamide prevents renal ischemia/reperfusion injury in rats.
    Kidney international, 2005, Volume: 67, Issue:5

    Topics: Adenosine Triphosphate; Animals; Cytokines; Diazoxide; Disease Models, Animal; Glyburide; Interleuki

2005
Antinociceptive effect of leaf essential oil from Croton sonderianus in mice.
    Life sciences, 2005, Oct-21, Volume: 77, Issue:23

    Topics: Acetic Acid; Analgesics; Animals; Behavior, Animal; Capsaicin; Croton; Disease Models, Animal; Dose-

2005
Atypical diabetes associated with inclusion formation in the R6/2 mouse model of Huntington's disease is not improved by treatment with hypoglycaemic agents.
    Experimental brain research, 2005, Volume: 166, Issue:2

    Topics: Administration, Oral; Animals; Behavior, Animal; Diabetes Mellitus; Disease Models, Animal; Exocytos

2005
The third gas: H2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis.
    Hepatology (Baltimore, Md.), 2005, Volume: 42, Issue:3

    Topics: Animals; Base Sequence; Carbon Tetrachloride Poisoning; Cystathionine gamma-Lyase; Disease Models, A

2005
Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke.
    Nature medicine, 2006, Volume: 12, Issue:4

    Topics: Adenosine Triphosphate; Animals; Astrocytes; ATP-Binding Cassette Transporters; Brain Edema; Brain I

2006
Antidiabetic and renoprotective effects of the chloroform extract of Terminalia chebula Retz. seeds in streptozotocin-induced diabetic rats.
    BMC complementary and alternative medicine, 2006, 05-07, Volume: 6

    Topics: Animals; Blood Glucose; Chloroform; Diabetes Mellitus, Experimental; Disease Models, Animal; Dose-Re

2006
Glibenclamide attenuates the antiarrhythmic effect of endotoxin with a mechanism not involving K(ATP) channels.
    Vascular pharmacology, 2007, Volume: 46, Issue:2

    Topics: Action Potentials; Adenosine Triphosphate; Animals; Arrhythmias, Cardiac; Blood Pressure; Carbamates

2007
Antispasmodic effects of Rooibos tea (Aspalathus linearis) is mediated predominantly through K+ -channel activation.
    Basic & clinical pharmacology & toxicology, 2006, Volume: 99, Issue:5

    Topics: Animals; Apigenin; Aspalathus; Beverages; Diarrhea; Disease Models, Animal; Dose-Response Relationsh

2006
Selective bronchodilatory effect of Rooibos tea (Aspalathus linearis) and its flavonoid, chrysoeriol.
    European journal of nutrition, 2006, Volume: 45, Issue:8

    Topics: Animals; Antihypertensive Agents; Aorta; Aspalathus; Bronchodilator Agents; Disease Models, Animal;

2006
Acute inflammation alters bicarbonate transport in mouse ileum.
    The Journal of physiology, 2007, Jun-15, Volume: 581, Issue:Pt 3

    Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Acute Disease; Adenylyl Cyclases; Animals; Antibod

2007
SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts.
    Basic research in cardiology, 2007, Volume: 102, Issue:4

    Topics: Androstadienes; Animals; Cardiotonic Agents; Disease Models, Animal; Dose-Response Relationship, Dru

2007
Effect of K+ATP channel and adenosine receptor blockade during rest and exercise in congestive heart failure.
    Circulation research, 2007, Jun-08, Volume: 100, Issue:11

    Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Blood Flow Velocity; Cardiac Pacing, Artifi

2007
Ischemic postconditioning reduces infarct size by activation of A1 receptors and K+(ATP) channels in both normal and hypercholesterolemic rabbits.
    Journal of cardiovascular pharmacology, 2007, Volume: 49, Issue:5

    Topics: Adenosine A1 Receptor Antagonists; Analysis of Variance; Animals; Anti-Arrhythmia Agents; Coronary C

2007
Role of ATP-sensitive potassium channels in the biphasic effects of morphine on pentylenetetrazole-induced seizure threshold in mice.
    Epilepsy research, 2007, Volume: 75, Issue:1

    Topics: Adenosine Triphosphate; Animals; Behavior, Animal; Blood Glucose; Cromakalim; Disease Models, Animal

2007
Chronic sodium hydrosulfide treatment decreases medial thickening of intramyocardial coronary arterioles, interstitial fibrosis, and ROS production in spontaneously hypertensive rats.
    American journal of physiology. Heart and circulatory physiology, 2007, Volume: 293, Issue:4

    Topics: Animals; Antihypertensive Agents; Blood Chemical Analysis; Blood Pressure; Cardiomegaly; Cardiotonic

2007
Endothelial sulfonylurea receptor 1-regulated NC Ca-ATP channels mediate progressive hemorrhagic necrosis following spinal cord injury.
    The Journal of clinical investigation, 2007, Volume: 117, Issue:8

    Topics: Animals; ATP-Binding Cassette Transporters; Behavior, Animal; Calcium Channels; Capillaries; Cells,

2007
COX-2-dependent and potentially cardioprotective effects of negative inotropic substances released after ischemia.
    American journal of physiology. Heart and circulatory physiology, 2007, Volume: 293, Issue:4

    Topics: Adenosine Triphosphate; Animals; Calcium Signaling; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenas

2007
Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways.
    Pflugers Archiv : European journal of physiology, 2008, Volume: 455, Issue:4

    Topics: Animals; Benzophenanthridines; Cardiotonic Agents; Cell Survival; Chromones; Disease Models, Animal;

2008
Effect of pravastatin on sympathetic reinnervation in postinfarcted rats.
    American journal of physiology. Heart and circulatory physiology, 2007, Volume: 293, Issue:6

    Topics: Animals; Blotting, Western; Cardiac Pacing, Artificial; Coronary Vessels; Disease Models, Animal; GA

2007
Acute antihypertensive action of Tempol in the spontaneously hypertensive rat.
    American journal of physiology. Heart and circulatory physiology, 2007, Volume: 293, Issue:6

    Topics: Amitrole; Animals; Antihypertensive Agents; Blood Pressure; Buthionine Sulfoximine; Catalase; Cromak

2007
Pial microvascular responses to transient bilateral common carotid artery occlusion: effects of hypertonic glycerol.
    Journal of vascular research, 2008, Volume: 45, Issue:2

    Topics: Animals; Blood Flow Velocity; Capillary Permeability; Carotid Artery, Common; Carotid Stenosis; Cell

2008
Intravenous nicorandil preserves endothelial junctions by decreasing endothelin-1 via activation of ATP-sensitive K+ channel.
    VASA. Zeitschrift fur Gefasskrankheiten, 2007, Volume: 36, Issue:3

    Topics: Animals; Antigens, CD; Cadherins; Coronary Vessels; Disease Models, Animal; Endothelial Cells; Endot

2007
Hyperoxia confers myocardial protection in mechanically ventilated rats through the generation of free radicals and opening of mitochondrial ATP-sensitive potassium channels.
    Clinical and experimental pharmacology & physiology, 2008, Volume: 35, Issue:1

    Topics: Acetylcysteine; Animals; Blood Pressure; Coronary Circulation; Decanoic Acids; Disease Models, Anima

2008
Role of the NO/cGMP/K(ATP) pathway in the protective effects of sildenafil against ethanol-induced gastric damage in rats.
    British journal of pharmacology, 2008, Volume: 153, Issue:4

    Topics: Animals; Arginine; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Diazoxide; Disease Mode

2008
Adenosine triphosphate-sensitive potassium channels prevent extension of myocardial ischemia to subepicardium during hemorrhagic shock.
    Shock (Augusta, Ga.), 2008, Volume: 30, Issue:2

    Topics: Animals; Coronary Circulation; Disease Models, Animal; Dogs; Glyburide; KATP Channels; Myocardial Is

2008
Effect of pressure overload on cardioprotection of mitochondrial KATP channels and GSK-3beta: interaction with the MPT pore.
    American journal of hypertension, 2008, Volume: 21, Issue:5

    Topics: Animals; Cardiotonic Agents; Cyclosporine; Diazoxide; Disease Models, Animal; Glyburide; Glycogen Sy

2008
KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury.
    Archives of pharmacal research, 2008, Volume: 31, Issue:4

    Topics: Animals; Aorta; Benzopyrans; Cardiotonic Agents; Decanoic Acids; Disease Models, Animal; Dose-Respon

2008
Ventricular overdrive pacing-induced preconditioning and no-flow ischemia-induced preconditioning in isolated working rat hearts.
    Journal of cardiovascular pharmacology, 1995, Volume: 25, Issue:1

    Topics: Animals; Benzopyrans; Blood Pressure; Cardiac Pacing, Artificial; Coronary Circulation; Cromakalim;

1995
Endothelinb receptor agonists produce pulmonary vasodilation in intact newborn lambs with pulmonary hypertension.
    Journal of cardiovascular pharmacology, 1995, Volume: 25, Issue:2

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Animals, Newborn; Argin

1995
Antifibrillatory effects of clofilium in the rabbit isolated heart.
    British journal of pharmacology, 1994, Volume: 113, Issue:1

    Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Decanoic Acids; Disease Models, Animal; Glyburid

1994
Blockade of ATP-sensitive potassium channels by 5-hydroxydecanoate suppresses monophasic action potential shortening during regional myocardial ischemia.
    Cardiovascular drugs and therapy, 1994, Volume: 8, Issue:5

    Topics: Action Potentials; Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bl

1994
Effects of diazoxide on norepinephrine-induced vasocontraction and ischemic myocardium in rats.
    Biological & pharmaceutical bulletin, 1994, Volume: 17, Issue:10

    Topics: Analysis of Variance; Animals; Aorta, Thoracic; Calcium; Diazoxide; Disease Models, Animal; Dose-Res

1994
The ATP-dependent potassium channel: an endogenous cardioprotective mechanism.
    Journal of cardiovascular pharmacology, 1994, Volume: 24 Suppl 4

    Topics: Acetylcholine; Adenosine; Animals; Anti-Arrhythmia Agents; Coronary Disease; Decanoic Acids; Disease

1994
Enhancement of ischemic myocardial metabolic derangement by glibenclamide.
    Japanese journal of pharmacology, 1994, Volume: 65, Issue:2

    Topics: Adenosine Monophosphate; Adenosine Triphosphate; Animals; Blood Glucose; Blood Pressure; Disease Mod

1994
Cardioprotective actions of potassium channel openers.
    European heart journal, 1994, Volume: 15 Suppl C

    Topics: Animals; Benzopyrans; Dihydropyridines; Disease Models, Animal; Dogs; Female; Glyburide; Male; Myoca

1994
Protection from ischaemic-reperfusion injury with adenosine pretreatment is reversed by inhibition of ATP sensitive potassium channels.
    Cardiovascular research, 1993, Volume: 27, Issue:4

    Topics: Adenosine; Adenosine Triphosphate; Animals; Disease Models, Animal; Dose-Response Relationship, Drug

1993
Glibenclamide does not abolish the protective effect of preconditioning on stunning in the isolated perfused rat heart.
    Cardiovascular research, 1993, Volume: 27, Issue:4

    Topics: Animals; Disease Models, Animal; Glyburide; Hydrogen-Ion Concentration; Magnetic Resonance Spectrosc

1993
Ischaemic preconditioning delays ischaemia induced cellular electrical uncoupling in rabbit myocardium by activation of ATP sensitive potassium channels.
    Cardiovascular research, 1993, Volume: 27, Issue:4

    Topics: Action Potentials; Adenosine Triphosphate; Animals; Culture Techniques; Disease Models, Animal; Fema

1993
Endothelin-1-induced reduction of myocardial infarct size by activation of ATP-sensitive potassium channels in a rabbit model of myocardial ischaemia and reperfusion.
    British journal of pharmacology, 1995, Volume: 116, Issue:6

    Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Arterial Occlusive Diseases; Blood Pressure

1995
Inhibition of ATP-activated potassium channels exerts pressor effects and improves survival in a rat model of severe hemorrhagic shock.
    Shock (Augusta, Ga.), 1996, Volume: 5, Issue:6

    Topics: Animals; ATP-Binding Cassette Transporters; Blood Pressure; Disease Models, Animal; Glyburide; Heart

1996
Myocardial protection in the acutely injured heart: hyperpolarizing versus depolarizing hypothermic cardioplegia.
    The Journal of thoracic and cardiovascular surgery, 1997, Volume: 113, Issue:3

    Topics: Animals; Cardioplegic Solutions; Coronary Circulation; Disease Models, Animal; Female; Glucose; Glyb

1997
KATP channel modulators increase survival rate during coronary occlusion-reperfusion in anaesthetized rats.
    European journal of pharmacology, 1997, Apr-11, Volume: 324, Issue:1

    Topics: Action Potentials; Adenosine Triphosphate; Analysis of Variance; Animals; Anti-Arrhythmia Agents; Ar

1997
[Protection afforded by a novel K channel opener (Y-26763), against glycerol-induced acute renal failure (ARF) in rats].
    Nihon Jinzo Gakkai shi, 1997, Volume: 39, Issue:5

    Topics: Acute Kidney Injury; Animals; Benzopyrans; Disease Models, Animal; Glyburide; Glycerol; Male; Potass

1997
Myocardial reactive hyperemia in experimental chronic heart failure: evidence for the role of K+ adenosine triphosphate-dependent channels and cyclooxygenase activity.
    Journal of cardiac failure, 1997, Volume: 3, Issue:3

    Topics: Animals; Cardiac Output, Low; Chronic Disease; Coronary Circulation; Cricetinae; Disease Models, Ani

1997
Role of impaired cAMP and calcium-sensitive K+ channel function in altered cerebral hemodynamics following brain injury.
    Brain research, 1997, Sep-12, Volume: 768, Issue:1-2

    Topics: Animals; Brain; Brain Injuries; Calcium; Cyclic AMP; Disease Models, Animal; Female; Glyburide; Hemo

1997
Microvascular permeability with sulfonylureas in normal and diabetic hamsters.
    Metabolism: clinical and experimental, 1997, Volume: 46, Issue:12 Suppl 1

    Topics: Animals; Calcium Channel Blockers; Calcium Channels; Capillary Permeability; Cricetinae; Dextrans; D

1997
In vitro and in vivo vasodilating effects of KRN4884, Ki1769 and Ki3005, pyridinecarboxamidine derivatives.
    Fundamental & clinical pharmacology, 1997, Volume: 11, Issue:6

    Topics: Animals; Antihypertensive Agents; Aorta, Thoracic; Blood Pressure; Disease Models, Animal; Dose-Resp

1997
Temporal relation of ATP-sensitive potassium-channel activation and contractility before cardioplegia.
    The Annals of thoracic surgery, 1998, Volume: 65, Issue:4

    Topics: Adenosine Triphosphate; Adrenergic beta-Agonists; Animals; Cardioplegic Solutions; Cardiotonic Agent

1998
The effect of subarachnoid hemorrhage on mechanisms of vasodilation mediated by cyclic adenosine monophosphate.
    Journal of neurosurgery, 1998, Volume: 89, Issue:1

    Topics: 4-Aminopyridine; Adenylyl Cyclases; Animals; Basilar Artery; Charybdotoxin; Colforsin; Cyclic AMP; D

1998
Mutually protective actions of kainic acid epileptic preconditioning and sublethal global ischemia on hippocampal neuronal death: involvement of adenosine A1 receptors and K(ATP) channels.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 1999, Volume: 19, Issue:12

    Topics: Animals; Disease Models, Animal; DNA Fragmentation; Epilepsy; Glyburide; Hippocampus; In Situ Nick-E

1999
Involvement of ATP-sensitive K(+) channels in the anti-tussive effect of moguisteine.
    European journal of pharmacology, 2000, Apr-28, Volume: 395, Issue:2

    Topics: Animals; Antitussive Agents; ATP-Binding Cassette Transporters; Cough; Disease Models, Animal; Drug

2000
Antiangiogenic effect of KR31372 in rat sponge implant model.
    The Journal of pharmacology and experimental therapeutics, 2001, Volume: 296, Issue:3

    Topics: Angiogenesis Inhibitors; Angiotensin II; Animals; Benzopyrans; Disease Models, Animal; Drug Interact

2001
Inhibition of the neuronal insulin receptor. An in vivo model for sporadic Alzheimer disease?
    Annals of the New York Academy of Sciences, 2000, Volume: 920

    Topics: Alzheimer Disease; Animals; ATP-Binding Cassette Transporters; Autoradiography; Brain; Cerebral Vent

2000
Hemodynamic effects of levcromakalim in neonatal porcine pulmonary hypertension.
    Biology of the neonate, 2001, Volume: 80, Issue:1

    Topics: Animals; Animals, Newborn; Blood Pressure; Cromakalim; Disease Models, Animal; Glyburide; Hemodynami

2001
Evaluation of the effects of nicorandil on experimentally induced gastric ulcers.
    Pharmacology, 2001, Volume: 63, Issue:3

    Topics: Animals; Anti-Ulcer Agents; Aspirin; Cimetidine; Disease Models, Animal; Dose-Response Relationship,

2001
Insulin secretion to glucose as well as nonglucose stimuli is impaired in spontaneously diabetic Nagoya-Shibata-Yasuda mice.
    Metabolism: clinical and experimental, 2001, Volume: 50, Issue:11

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e

2001
Mouse model of Prinzmetal angina by disruption of the inward rectifier Kir6.1.
    Nature medicine, 2002, Volume: 8, Issue:5

    Topics: Angina Pectoris, Variant; Animals; Aorta, Thoracic; Blood Pressure; Coronary Vessels; Disease Models

2002
Effect of adenosine triphosphate-sensitive potassium channel openers on lung preservation.
    American journal of respiratory and critical care medicine, 2002, Jun-01, Volume: 165, Issue:11

    Topics: Adenosine Triphosphate; Animals; Disease Models, Animal; Glyburide; Hypertension, Pulmonary; Lung; P

2002
[Relation of uric acid and arteriosclerosis on an experimental model of chickens fed with eggs. Influence of insulin and oral antidiabetics (glibenclamide and tolbutamide)].
    Revista clinica espanola, 1975, Nov-15, Volume: 139, Issue:3

    Topics: Animals; Arteriosclerosis; Chickens; Cholesterol, Dietary; Disease Models, Animal; Eggs; Glyburide;

1975
Effects of drugs on ventricular fibrillation and ischaemic K+ loss in a model of ischaemia in perfused guinea-pig hearts in vitro.
    European journal of pharmacology, 1992, Sep-22, Volume: 220, Issue:2-3

    Topics: 4-Aminopyridine; Animals; Anti-Arrhythmia Agents; Benzothiazoles; Calcium Channel Blockers; Disease

1992
[The vasospasmolytic effects of nicorandil, cromakalim and pinacidil on 3,4-diaminopyridine-induced phasic contractions in canine coronary arteries as an experimental vasospasm model].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1992, Volume: 100, Issue:4

    Topics: 4-Aminopyridine; Amifampridine; Animals; Benzopyrans; Coronary Vasospasm; Cromakalim; Disease Models

1992
[Glibornuride, a new high-effective antidiabetic agent. Pharmacological and biochemical comparative studies in various animal species and animal experimental models].
    Arzneimittel-Forschung, 1972, Volume: 22

    Topics: Administration, Oral; Animals; Blood Glucose; Camphanes; Chemical Phenomena; Chemistry; Cholesterol;

1972